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Abstract
Femoral augmentation is a minimally invasive procedure involving injection of bone
cement into osteoporotic femora in order to enhance their load capacity. However, this
treatment poses significant risks such as bone thermal necrosis or embolism when large
amounts of bone cement are injected in the femur. This thesis presents methods
developed to find the ideal bone cement volume and distribution needed to restore the
load capacity of osteoporotic femora depending on their level of osteoporosis. Material
properties of augmented tissue were modelled using a proposed scheme that combines
Voigt-Reuss-Hill average and bone cement porosity. These ideal bone cement
distributions were used as a reference to propose several feasible and generalised
augmentation strategies, which comprised placing bone cement in up to three spheres or
in up to two pre-drilled channels. Bone cement location was found to be more significant
in the augmentation result than bone cement volume or augmentation strategy.
Fracture analysis of augmented femora was also conducted, demonstrating that
approximately 7ml of bone cement can result in an increase of 74% in yield load, 62% in
fracture load, and 117% in energy to fracture. After finding the optimum bone cement
volume and distribution, the bone cement injection and polymerisation process was
studied in a 2D femur model, and results suggest that risk of thermal necrosis was
limited to the regions in the bone-PMMA interface while stress levels required to
develop debonding between the materials were not reached. However, results were
obtained from a 2D model and the bone-PMMA interface was not modelled in detail.
Some other limitations involved in the present study are the use of a single femur, with
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virtually introduced osteoporosis that only represents senile osteoporosis and a single set
of boundary conditions. Additionally, despite results were compared against experiments
in the literature, an experimental validation may be necessary to ensure the validity of
the model. Despite the limitations of the present study and lack of direct experimental
validation, the methods presented in this thesis can be applied to any femur to evaluate
the requirements of femoral augmentation and the risks that it may entail. When
applied to the studied femur, we conclude that femoral augmentation can increase
significantly the femur yield and fracture load and only present risk of thermal necrosis
in the bone-PMMA interface.
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Chapter 1
Introduction
Osteoporotic hip fractures consist of cracks or breaks in the upper part of the femur due
to a load that would not typically fracture a healthy bone. Given their severe
consequences and extended recovery times, they are responsible for 47% of the total cost
of osteoporotic fractures in the UK (Svedbom et al., 2013). Hence, several preventative
treatments including drugs, hip protectors, specific diets and exercises and calcium and
vitamin D supplementation have been proposed in the past. However, due to their side
effects and lack of patient compliance their efficacy is limited. Femoral augmentation is
a preventive treatment against osteoporotic hip fractures that should not present these
drawbacks. It involves reinforcing the proximal femur using an injectable bone cement
and aims to restore the reduced load-bearing capacity of the bone. Due to the risks
associated when injecting large volumes of bone cement, this procedure is not currently
applied in clinical practice. Hence, before applying this treatment in vivo, two
unknowns need to be addressed: the minimum amount of bone cement required and its
distribution to avoid an osteoporotic hip fracture and the risks that the procedure would
involve with the minimum amount of bone cement. Given the large number of factors
that can affect the outcome of femoral augmentation (degree of osteoporosis, type of
bone cement, volume and distribution of bone cement, type of fall), a numerical study is
1
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an efficient approach to find answers to the aforementioned unknowns. In more detail,
the aims and objectives of the present numerical investigation are detailed below.
1.1 Aims and Objectives
The aim of this research was to numerically investigate the feasibility and consequences
of the femoral augmentation procedure. To this end, the following objectives were set:
• Develop a computational model to study the biomechanical effect of femoral
augmentation including accurately modelling the mechanical properties of
augmented tissue.
• Investigate how the degree of osteoporosis affects the requirements and
biomechanical outcome of femoral augmentation.
• Propose and study a range of generalised and patient-specific augmentation
approaches.
• Identify optimal bone cement volume and placement for the proposed femoral
augmentation strategies.
• Develop a computational model to investigate the risk of bone thermal necrosis
and debonding between bone tissue and bone cement during the augmentation
procedure.
1.2 Thesis Overview
This thesis presents a numerical study of femoral augmentation and is structured as
follows:
2
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• Chapter 2 presents an introduction to osteoporosis and osteoporotic hip fractures,
a review of current risk assessment strategies and existing preventative treatments
for these fractures. From all preventative treatments, a literature review of femoral
augmentation is presented, including the advantages and disadvantages that the
procedure can entail.
• In Chapter 3, the ideal locations where bone cement should be placed to prevent
an osteoporotic hip fracture are found. To achieve this, femur Finite Element (FE)
models with different levels of osteoporosis and osteopenia were developed based on
a CT scan. FE analyses of the femora under lateral fall conditions were conducted
and an Evolutionary Structural Optimisation (ESO) algorithm was applied to find
the ideal distribution of bone cement. However, the obtained ideal distribution of
bone cement is not constrained to be realistic and injectable in practice.
• In Chapter 4, a set of modifications that could improve the approach used in Chapter
3 to model the augmented tissue are proposed. These modifications involve the use
of a rule of mixtures, consideration of bone volume fraction per element and bone
cement porosity. Five different modelling approaches are proposed and a statistical
analysis is performed to find if they are significantly different from each other.
Additionally, the effect of fall direction and bone cement porosity on the femoral
augmentation requirements is investigated through a sensitivity analysis.
• In Chapter 5, an important limitation of Chapters 3 and 4 is addressed: the lack of
realistic augmentation strategies. To do so, several realistic femoral augmentation
strategies are proposed based on the ideal bone cement distribution found in previous
chapters. These augmentation strategies are based on injecting cement in one or
two pre-drilled paths or injecting cement in up to three spheres. The different
augmentation approaches are studied through the use of FE and Taguchi analyses
and their placement is optimised using a patternsearch algorithm.
• Chapter 6 studies the possible changes in fracture patterns that can occur due to
the femoral augmentation procedure. Based on the realistic, optimised
3
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augmentation strategies found in Chapter 5, a fracture analysis is performed in
augmented and non-augmented femora using FEA and a nonlocal damage model.
Changes in fracture patterns are studied to determine if augmentation with
PMMA bone cement can lead to more complicated fractures.
• Chapter 7 investigates the risks involved in the femoral augmentation procedure
due to the injection and solidification of bone cement inside the femur. Using
the augmentation strategies proposed in previous chapters, a 2D computational
framework is applied to simulate the bone cement injection and curing processes
in femoral augmentation. Intraosseous pressure, temperature fields and stresses are
studied to evaluate the risks of leakage, thermal necrosis and debonding.
• Chapter 8 presents a summary of the obtained results, limitations of the current
study and recommendations for future work.
4
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Background
2.1 Osteoporosis
Bone is a dynamic tissue that develops in three main stages: growth, modelling and
remodelling. During childhood and adolescence bone tissue grows with accompanying
changes to shape and thickness influenced by environmental factors. For men and women
of normal body weight, total skeletal mass reaches its peak at the end of the growth period,
a few years after the fusion of the long bone epiphyses. Bone mass of an individual in
later life will depend on the peak attained during growth and subsequent rate of bone
loss. The remodelling phase occurs during adulthood and continues throughout life when
tissue is lost by resorption and rebuilt by formation. In normal bone remodelling, a
balance between bone resorption and bone formation is maintained to ensure that bone
mass and mechanical strength remain the same after each cycle (Feng and McDonald,
2011). However, an imbalance between bone formation and resorption can lead to bone
loss and the development of bone disorders such as osteoporosis.
Osteoporosis is a disease characterized by low bone mass, deterioration of bone tissue
and disruption of bone microarchitecture (NIH Consensus Development Panel on
5
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Osteoporosis Prevention, 2001) that can lead to compromised bone strength and
increased risk of fractures. This disease can be divided into two subtypes: type I and
type II (Riggs et al., 1982, 2001). Type I osteoporosis appears solely in postmenopausal
women and is mainly caused by oestrogen deficiency resulting from menopause, whereas
type II osteoporosis is associated primarily with aging in both women and men. In both
types of osteoporosis, the condition is directly related to the decrease of bone mineral
density (BMD). This decrease affects the microstructure of the bone and explains the
lowering of bone strength and higher risk of fracture. Currently, the diagnosis of
osteoporosis is based on the BMD of the femoral neck, measured using dual-energy x-ray
absorptiometry (DXA). According to the World Health Organization, osteoporosis is
defined as having a BMD below 2.5 standard deviations of the young adult average
value (T-Score equal or less than -2.5). Table 2.1 shows the diagnostic criteria in detail
(Kanis, 2002):
Table 2.1: Osteoporosis levels based on T-Score.
Condition T-Score
Normal -1.0 or higher
Osteopenia Between -1.0 and -2.5
Osteoporosis -2.5 or lower
Severe Osteoporosis -2.5 or lower and personal history of fragility fractures
Osteoporotic fractures commonly occur in the distal radius, proximal humerus, vertebral
bodies, pelvis and the proximal femur (Compston et al., 2017). Each year in the UK,
approximately 536,000 new fragility fractures occur, including 79,000 hip fractures,
66,000 vertebral fractures and 69,000 forearm fractures (Svedbom et al., 2013). These
fractures constitute a major burden to the health care system and the economy due to
hospitalisation costs, disability, loss of independence and increase of early mortality
levels. Moreover, the increased longevity of the world population will lead to a
significant rise in fragility fractures if improvements are not made to bone health
awareness and elderly healthcare practice (Gullberg et al., 1997; Kanis, 2002; Svedbom
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et al., 2013). Therefore, the early identification of patients at high risk of fracture and
the development of new preventative strategies will be crucial for more effective
management of patients with osteoporosis.
2.2 Hip Fractures
The present study is focused on hip fractures, which are defined as a partial or complete
break in the proximal region of the femur, close to the hip joint. Despite representing
less than 15% of the total fragility fractures occurring annually in the UK, they account
for 47% of the total cost of osteoporotic fractures due to their severe consequences and
associated extended recovery times (Svedbom et al., 2013). Additionally, hip fractures
are associated with significant morbidity, mortality and lack of independence (Cummings
and Melton, 2002). Approximately 53% of patients suffering a hip fracture can no longer
live independently (Neuburger et al., 2015) and the risk of mortality increases by 20% in
the year following a hip fracture (Leibson et al., 2002). Furthermore, due to the ageing
of the world’s population the incidence of hip fractures is increasing by 1-3% per year in
most areas of the world (Cummings and Melton, 2002).
2.2.1 Femur Anatomy
In order to better understand the types and risk of hip fractures, a brief description of
the proximal femoral anatomy is provided. The femur is the longest bone in the human
body, connecting the hip and knee and transmitting forces from the tibia to the hip joint.
The proximal femur forms the hip joint with the pelvis, and it is comprised of the head,
the neck, and two trochanters (Figure 2.1). The femoral head is a half-spherical region
covered by cartilage, which connects with the pelvis through the acetabulum, forming the
hip joint. The femoral neck constitutes the main support of the femoral head, connecting
it to the femoral shaft. The greater and lesser trochanters are located in the lateral region
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of the femur and have a complex geometry due to the presence of muscle, ligament and
tendon connections. Both cortical and trabecular bone are present in different regions of
the femur. Trabecular bone is a porous tissue, with 50 to 90% porosity, while cortical
bone is solid, strong and denser than trabecular bone, with only 5 to 10% porosity. The
femoral shaft has a thick layer of cortical tissue, which decreases progressively towards
the neck area until becoming a very thin layer in the proximal femur.
Greater trochanter
Femoral neck
Lesser trochanter
Femoral head
Figure 2.1: Proximal femur anatomy.
Fractures of the femur will occur when the force acting in the bone exceeds its capacity
to dissipate the related energy without suffering damage (Nobile and Nobile, 2019). This
energy to failure is shown in Figure 2.2 as the area under the stress-strain curve limited
by the maximum stress (ultimate strength) and strain (ultimate strain) that the bone can
sustain. Additionally, this curve is formed of an elastic strain region and a plastic strain
region, separated by the yield point (Turner, 2006). Stresses above the yield point (forces
higher than the bone yield load) would cause permanent damage to the bone.
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Figure 2.2: Typical stress-strain curve for bone (Turner, 2006).
2.2.2 Hip Fracture Classification
The proximal femur carries a variety of loads during daily activities and subsequently
presents different fracture configurations which are strongly affected by hip geometry,
environmental factors, and health conditions such as osteoporosis (Gomez-Alonso et al.,
2000; Kaptoge et al., 2008; Marks, 2010). Depending on fracture location, hip fractures
are classified into three types: femoral neck, trochanteric and femoral head fractures.
Femoral neck fractures occur in the region of the upper femur located between the femoral
head and the trochanters. These fractures can be classified according to their location
in subcapital, transcervical or basicervical and can be displaced or non-displaced (Figure
2.3). The blood supply to the femoral head depends on several arteries that pass through
the femoral neck region. Hence, displacement of the femoral neck can restrict blood
supply to the femoral head and lead to necrosis (Fox et al., 2000). Elderly individuals
with reduced BMD tend to present subcapital femoral neck fractures from low-energy falls
(Parkkari et al., 1999), while young adults often present vertically oriented distal neck
fractures associated with high-energy trauma (Riggs et al., 2001; Winter et al., 2016).
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Femoral neck fractures have also been associated with Parkinson’s disease (Fisher et al.,
2010), oestrogenic therapy (Fox et al., 1999) and variations in hip morphology (Pulkkinen
et al., 2011).
Subcapital Transcervical Basicervical
Pertrochanteric Intertrochanteric
Split Depression
Figure 2.3: Classification of femoral neck fractures.
Trochanteric fractures occur out of the joint capsule (extracapsular), in the area between
the greater and lesser trochanters. Depending on their location, they can be classified as
pertrochanteric or intertrochanteric fractures (Figure 2.4). These areas involve bone with
good local blood supply, reducing the possibility of bone necrosis. However, they contain
numerous muscle attachments, which may exert forces capable of pulling bone segments
out of alignment. Fractures of the trochanter are usually associated with elderly patients
with a previous fracture history (Fox et al., 1999), low BMD, and vitamin D deficiency
(Pulkkinen et al., 2011).
Subcapital Transcervical Basicervical
Pertrochanteric Intertrochanteric
Split Depression
Figure 2.4: Classification of trochanteric femoral fractures.
Finally, fractures of the femoral head are classified into split fractures and depression
fractures (Figure 2.5). Femoral head fractures are rare and normally occur in young
adults as the result of a high-energy traumatic hip dislocation (Alonso et al., 2000).
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Subcapital Transcervical Basicervical
Pertrochanteric Intertrochanteric
Split Depression
Figure 2.5: Classification of femoral head fractures.
2.2.3 Risk Assessment
Epidemiological evidence suggests most osteoporotic hip fractures occur due to a lateral
fall on the greater trochanter from standing height or lower (Parkkari et al., 1999; Turner,
2002). However, despite falls in the elderly being frequent (Sanders et al., 2017), only
about 5% of falls are reported to result in a fracture (Nachreiner et al., 2007). Therefore,
the risk of suffering a hip fracture due to a fall can be defined as the femur’s ability to
resist the force that it encounters in case of a fall.
Multiple factors such as advancing age, family history of fracture, personal history of
previous fractures and/or falls, sex, excessive bone loss, low BMD, low body weight,
and smoking habits have been associated with fracture risk (Cummings et al., 1995).
From these, the most robust predictors are low BMD and existence of previous fractures
(LaFleur et al., 2008; Klotzbuecher et al., 2000), although they are unable to account for all
fracture cases on their own. For instance, among those aged over 50 years old, more than
50% of women and up to 70% of men who sustained a fracture had not had osteoporosis as
defined by the BMD criteria (Nguyen et al., 2007a). For this reason, a number of models
for fracture risk assessment have been developed based on the idea of incorporating data
from multiple factors. To date, the most common models used in clinical practice are
FRAX (Kanis et al., 2008) and the Garvan Fracture Risk Calculator (Nguyen et al.,
2007b). FRAX uses 12 risk factors such as femoral neck BMD, anthropometric and
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lifestyle factors, and comorbidities. The Garvan Fracture Risk Calculator uses 5 risk
factors: age, sex, femoral neck BMD, prior fracture, and history of falls. Unfortunately,
these tools are limited in their ability to accurately detect patients at risk due to their
ethnic specificity and not taking into account the magnitude of the fall-induced impact
force (Watts et al., 2009; Geusens et al., 2010; Ja¨rvinen et al., 2014). However, recent
advances in statistical modelling and machine learning have opened new opportunities for
improving this type of fracture prediction models (Kruse et al., 2017; Ferizi et al., 2019).
A different approach to predict the risk of hip fractures consists of simulating falls onto
soft protective surfaces with human volunteers (Svedbom et al., 2013; Laing and
Robinovitch, 2010). Using the soft protective surfaces reduces the load acting on the
volunteers’ femur, so in order to predict the real forces at impact conditions these
models rely on extrapolation beyond the force range for which they were validated.
Ex-vivo models, using cadaveric or synthetic femora and following the same
methodology can replicate a fall up to the fracture point (Gilchrist et al., 2014; Fleps
et al., 2018). However, most systems fail to accurately represent the patient-specific
fracture loads or the soft tissue and pelvis surrounding the bone.
Subject-specific finite element (FE) models show potential as a tool to improve the
accuracy of fracture risk prediction. These models may estimate bone strength and
characterise the bone mechanical behaviour under different loading conditions. Several
FE studies have examined the differences in femoral strength under various load
configurations such as single stance (Cody et al., 1999; Keyak, 2001; Keyak and
Falkinstein, 2003) or fall in different directions (Ford et al., 1996; Pinilla et al., 1996;
Majumder et al., 2007; Grassi et al., 2012). Moreover, FE models have proven to be
better predictors of femoral strength than BMD based on DXA images (Cody et al.,
1999). However, despite a few studies attempting to show their applicability in clinical
settings (Floerkemeier et al., 2011; Eggermont et al., 2018; Benca et al., 2019), there are
still several reasons as to why FE models are not widely used in clinical practice. One
concern is the reproducibility of FE models, since the procedure to generate such models
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involves several steps like image segmentation, meshing, materials and boundary
conditions assignment. The execution of each one of these steps varies between
published studies in terms of different input parameters and level of detail implemented
(van den Munckhof and Zadpoor, 2014). Another concern is related to the fact that the
majority of proposed FE modelling techniques are based on computed tomography (CT)
datasets. When compared with DXA, performing a CT scan involves higher operational
costs and subjects patients to a higher radiation dose (Kanis, 2002; Engelke et al.,
2015). Subject-specific FE models from DXA images have the potential to overcome
some of these issues. The process to build these models consists of using statistical tools
to reconstruct 3D shape and BMD distribution from a planar DXA image (Langton
et al., 2009). Their accuracy predicting femoral strength has been reported to be only
slightly inferior to those obtained with state-of-the-art CT-based models (Grassi et al.,
2017), suggesting such models could potentially be used in clinical settings to improve
hip fracture risk assessment.
2.3 Prevention of Hip Fractures
Due to the serious consequences of osteoporotic hip fractures and the world’s ageing
population, numerous methods for the prevention of such fractures have been developed
over the past years. These include specific weight-bearing exercises to stimulate bone
growth, calcium and vitamin D supplementation, pharmacological treatments to prevent
or treat osteoporosis and interventions to reduce the risk and consequences of falling.
2.3.1 Pharmacological Prevention
Pharmacological treatment of osteoporosis plays an important role in the prevention of
osteoporotic fractures and have been shown to reduce risk of vertebral and hip fractures
(Kanis et al., 2013). However, the majority of drugs are limited by side effects and the
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long time taken to restore bone properties. Besides this, due to the slow and progressive
nature of osteoporosis it is difficult to maintain patient compliance with scheduled
dosing (Kothawala et al., 2007). To date, most pharmacological treatments for
osteoporosis are based either on inhibiting bone resorption (antiresorptive agents) or
stimulating bone formation (osteoanabolic agents). However, use of antiresoptives such
as calcium, vitamin D, bisphosphonates, selective oestrogen receptor modulators, and
oestrogen is usually followed by a decrease in bone formation, limiting their efficacy.
Similarly, use of osteoanabolics increases bone formation but also increases bone
resorption. Therefore, attempts are currently being made to develop molecules that can
overcome this issue and achieve uncoupling of bone formation from bone resorption
(Makras et al., 2015). The current most common pharmacological treatments for the
prevention of osteoporotic fractures are detailed below:
• Calcium and vitamin D
The effect of calcium and vitamin D supplements on osteoporosis and fracture risk depends
on several factors which include dosing, combinations of calcium and vitamin D and type
of ingestion (van der Velde et al., 2014). It has been proved that mono-supplements
with calcium have no effect on the development of osteoporosis (Abrahamsen, 2017) but
mono-supplementation with vitamin D can reduce the risk of osteoporotic fractures in
subjects with a high vitamin D deficiency (Bischoff-Ferrari et al., 2018). In the case of
supplements combining calcium and vitamin D, it has been shown that these measures can
decrease the risk of hip fracture in elderly institutionalized adults (Chapuy et al., 1992), as
well as the risk of non-vertebral fractures in men and women over the age of 65 (Trivedi
et al., 2003; Bischoff-Ferrari et al., 2009). Therefore, evidence suggests that providing
calcium and vitamin D supplements to individuals at high risk of deficiencies or patients
receiving anti-osteoporosis drugs could help prevent osteoporotic fractures (Harvey et al.,
2017). A range of side effects such as gastrointestinal intolerance, kidney stones and
cardiovascular problems (Bolland et al., 2015) have been reported due to calcium and/or
vitamin D supplementation. Hence, despite these two supplements demonstrating strong
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benefits against osteoporotic fractures, they also entail a renal and cardiovascular risk
(Abrahamsen, 2017).
• Bisphosphonates
Bisphosphonates have been the most commonly used treatment for osteoporosis since
the late 1960s. They are antiresorptive agents that inhibit the resorption of bone and try
to restore the balance between bone loss and formation. Alendronate and risedronate
are the most commonly used bisphosphonates due to their efficacy and low cost. A
randomized placebo-controlled trial of alendronate showed a 47% reduction in hip
fractures after 12 months of continuous dosing (Black et al., 2000). Similarly, a trial of
risedronate demonstrated a significant reduction in hip fracture risk after 24 months of
therapy (McClung et al., 2001). Bisphosphonates are well tolerated by most people, but
side effects such as hypocalcemia, severe muscular pain, and ocular inflammation are
likely to occur in calcium and vitamin D deficient patients. However, the main concern
with this treatment is that prolonged use may result in suppression of osteoclasts and
osteoblasts which may cause reduced bone remodelling, impairing the repair of
micro-cracks in bone and leading to atypical femoral fractures (Dell et al., 2012).
• Hormone replacement therapy
Hormone replacement therapy (oestrogen) is an antiresorptive treatment that inhibits
bone resorption and maintains bone formation. Oestrogen treatment was formerly the
primary choice for prevention of osteoporosis in menopausal women. A study developed
by the Women’s Health Initiative (WHI) proved the effectiveness of this treatment in
the reduction of hip fracture risk, but also reported increases in breast cancer risk,
cardiovascular disease and venous thromboembolic events (Rossouw et al., 2002). Hence,
despite this treatment proving beneficial to post-menopausal women, due to its severe
adverse effects, this therapy is no longer recommended in the elderly population.
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• Selective oestrogen receptor modulators
Selective oestrogen receptor modulators (SERMs) were developed to maintain the benefits
of oestrogen therapy but avoid its potential side effects. SERMs such as raloxifene and
bazedoxifene act like oestrogen on bone processes (decreasing bone resorption) but exhibit
the effects of an anti-oestrogen on uterus, breast and brain tissue. A meta-analysis of
seven randomized trials in postmenopausal women with osteoporosis following a raloxifene
treatment showed a reduction of 30% in vertebral fractures but no risk reduction for non-
vertebral fractures (Cranney et al., 2002). In a different study, therapy with bazedoxifene
and raloxifene was studied, showing a significant effect on maintaining BMD and reducing
the incidence of new vertebral fractures (Kaufman et al., 2013). Further trials examining
various SERM preparations have shown that BMD can be maintained and incidence of
vertebral fractures reduced, yet risk of non-vertebral fractures did not decrease. All these
studies indicate that the benefits of SERMs might be anatomically limited and their
effectiveness is curtailed once the medication is suspended. The side effects of SERMs
include increased risk of venous thromboembolic events and incidence of hot flashes.
2.3.2 Non-pharmacological Prevention
Non-pharmacological osteoporosis management is a broad concept that includes nutrition,
physical exercise and wider lifestyle changes. It has been shown that lifestyle habits can
contribute up to 20% of the variation in peak bone mass attainment, as well as to the rate
of bone loss in adults (Rubin et al., 1999; Drake et al., 2004). For this reason, healthy
lifestyle habits such as adequate calcium intake and weight-bearing exercise should be
part of the long-term approach for the prevention of fragility fractures, for all sexes and
ages.
Falls are the major health concern for people with diagnosed osteoporosis. Between 28%
and 35% of community-living adults over 65 years old experience at least one fall each year
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(Campbell et al., 1981; Blake et al., 1988), and the likelihood of suffering falls increases
with ageing (Masud and Morris, 2001). For those living in nursing care facilities, the
annual risk of falls increases to up to 70% (Cameron et al., 2010). Therefore, due to
the severe impacts of some fragility fractures, fall prevention and hip protectors are key
preventative measures. Physical therapy and exercise such as Tai Chi, and gait and
strength training have been thoroughly investigated as methods to prevent falls in the
elderly (Chang et al., 2004; Gillespie et al., 2012). These activities have been effective
in reducing the fear of falling in older people (Zijlstra et al., 2007) and have shown a
35% reduction in the number of falls and fall-related injuries in adults over 65 years old
(Robertson et al., 2002). In some cases, fall prevention requires home safety assessment
and environmental modifications, which have proven to significantly reduce the number
of falls in adults with fall history or severe visual impairment (Gillespie et al., 2012).
Since the majority of osteoporotic hip fractures occur due to a sideways fall with impact
on the greater trochanter (Parkkari et al., 1999), a proposed preventative measure is to
use a device to protect the hip. A hip protector is a plastic shell that fits around the
hip and is generally fixed to specialised undergarments. They are designed to absorb
the energy from a fall, decreasing the force on the trochanter and avoiding the fracture.
Numerous trials have examined the effect of external hip protectors on the incidence of hip
fractures, but findings have been conflicting. In a number of studies, hip protectors did
significantly reduce the incidence of hip fractures (Lauritzen et al., 1993; Kannus et al.,
2000; Chan et al., 2000), while in others it did not show statistical significance (Cameron
et al., 2001; Schoor et al., 2003; Kiel et al., 2007). In addition to the inconsistency of the
results, the main concerns with external hip protectors are discomfort and poor patient
compliance (Zimmerman et al., 2010).
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2.4 Femoral Augmentation
Femoral augmentation (also known as femoroplasty) is a procedure that may prevent
osteoporotic hip fractures and involves the reinforcement of the proximal femur using
injectable bone cement. The procedure consists of drilling a path into the proximal
femur and then filling the drilled cavity and inner bone with bone cement. Initially the
bone cement is in the form of a viscous dough, and a few minutes after being injected
inside the bone it polymerises and solidifies. The solid bone cement should help restore
the strength of the osteoporotic femur, improving its ability to withstand physiological
loading conditions and low-impact falls. From a biomechanical perspective, properties
such as fracture load, yield load and energy to fracture are expected to increase after the
procedure. Moreover, given that it is a minimally invasive surgery, femoral augmentation
should require low hospitalization costs and a short recovery time.
However, there are risks associated with this treatment that must be addressed before
proceeding to in vivo application. First, if PMMA (polymethylmethacrylate) is used as
the reinforcing agent, there is risk of thermal necrosis due to the exothermic reaction
generated during the polymerisation stage. The maximum temperature reached in the
process is directly related to the volume and distribution of bone cement. Thermal
necrosis may occur in the tissues surrounding the PMMA if they are exposed to a
temperature of 56°C for over 10 seconds (Pearce et al., 2005). Given the toxic nature of
the monomer in PMMA there is also risk of infection and allergic reaction to the
augmentation material. Additionally, injecting bone cement into the trabecular tissue
might have an adverse effect on the blood supply of bone and adjacent soft tissues, as
well as increasing the intraosseous pressure. Further, if bone cement leaks into the blood
vessels, it can lead to fat embolisms (Geraci et al., 2013). Finally, patients with
osteoporosis who have undergone femoral augmentation may develop a fracture as a
result of the stiffness discontinuity between the augmented and the non-augmented
regions of the femur. In this case, femoral augmentation might change the location of
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the fracture or damage the areas near the bone cement but not avoid the fracture.
2.4.1 Augmentation Strategies
Most experimental studies of femoral augmentation have been performed in vitro using
paired cadaveric femora. One of the femora is randomly chosen as the control and the
contralateral as the specimen for augmentation. Mechanical tests are then performed
under two main loading conditions: single-leg stance or lateral fall onto the greater
trochanter, with the latter being most common. In this scenario, there is a significant
variation amongst studies regarding the inclination to the horizontal plane and the load
displacement rate. However, the factor dividing experiments into two main categories
(first-generation and second-generation) is the injected volume of bone cement.
First-generation studies tend to inject large amounts of cement (30 to 50ml) into the
bone, with the primary aim being to fill most of the proximal femur and stopping the
injection if leakage occurs (Heini et al., 2004; Beckmann et al., 2007; van der Steenhoven
et al., 2009; Sutter et al., 2010a). Most of these studies support the hypothesis that
femoral augmentation strengthens the bone, although results depend to a large extent
on the augmentation material. Using on average 36ml of PMMA, Heini et al. (2004)
achieved an increase of 188% in the energy to failure of the augmented femur and of 82%
in the fracture load. However, the significant improvement in biomechanical properties
also involved a femoral surface temperature rise of 22.1°C.
In order to avoid the high temperatures reached in the curing process of PMMA,
Beckmann et al. (2007) used Cortoss®, which is a composite-cement with a reduced
exothermic curing process, to reinforce 9 pairs of osteoporotic femora. Results after
injecting 40ml of the composite showed a lower surface temperature rise compared to
augmentation with PMMA (temperature increase of approximately 11°C) and
significant improvement in the femur mechanical properties (187% increase in the energy
to fracture and 43% in the fracture load). Similar results were obtained by Sutter et al.
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(2010a), who used 47ml of PMMA and achieved a gain of 154% in the energy to fracture
and of 37% in the ultimate load. van der Steenhoven et al. (2009) also attempted to
overcome PMMA high temperatures during polymerisation through the use of a silicone
rubber that cures without exothermic heat (polydimethylsiloxane; PDMS) as the
reinforcing agent. Using PDMS reduced the fracture displacement, but since it is not a
stiff material the femur fracture load decreased after augmentation.
Second-generation experiments take into account cement placement and inject a reduced
volume (8 to 15ml) of cement (Sutter et al., 2010b; Beckmann et al., 2011; Steenhoven
et al., 2011; Fliri et al., 2013; Springorum et al., 2014; Basafa et al., 2015; Raas et al.,
2016). The optimum cement distribution inside the bone and augmentation technique
remain unclear, so studies continue to use a variety of approaches. The majority of
authors agree that it is necessary to drill at least one channel into the bone to facilitate
cement injection. However, Beckmann et al. (2011) found that drilling two paths into
the proximal femur weakened too much the cortical bone and led to decreased bone
strength after the augmentation procedure. Moreover, Steenhoven et al. (2011) studied
the difference between creating the cavity in the femoral neck with a drill or with and
inflatable balloon. The balloon technique required an additional 4ml of bone cement
compared to the conventional drilling technique but there were no significant differences
in the augmented femur biomechanical properties. Also, in order to have more control
over the procedure, some studies use fluoroscopic guidance while injecting the cement
(Sutter et al., 2010b; Steenhoven et al., 2011; Springorum et al., 2014) or a navigation
system to drill the injection paths accurately (Basafa et al., 2015).
Regarding bone cement placement, Sutter et al. (2010b) injected 15ml of cement and
studied the difference between cementing the femoral neck or the greater trochanter.
Augmentation of the femoral neck achieved slightly better results, although no techniques
substantially increased the ultimate load or the energy to fracture. A different approach
is V-Shaped augmentation, which consists on reinforcing the femur through two channels
parallel to the superior and inferior femoral neck. Fliri et al. (2013) used this augmentation
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technique and replicated a lateral fall onto the greater trochanter. On average, 10.8ml of
PMMA were injected into the femur, leading to an increase in energy absorption of 124%
but no change in the fracture or yield load. In a more recent study, Raas et al. (2016)
injected 13ml of bone cement in a V-shaped augmentation but tested the femora using
single leg stance configuration. The outcome of the study showed that the resistance
to fracture did not increase significantly. Beckmann et al. (2011) tested four different
cementing techniques and concluded that the optimum approach was injecting 12ml of
PMMA into a single centrodorsal drilled cavity in the femoral neck. This technique
managed to increase the energy to fracture by 164% and the ultimate load by 35%. The
same technique was applied by Springorum et al. (2014), who recorded a rise of energy
to failure by 117% and fracture load by 33% using 8-15ml of cement. In a recent in
vitro study, Stroncek et al. (2019) investigated the injection of a resorbable triphasic
calcium sulphate/calcium phosphate material (AGN1) into the proximal femur. This
material is designed to be resorbed and replaced by new bone and its exothermic reaction
does not exceed 35°C. After injecting 19ml of AGN1 from the greater trochanter to the
femoral neck and replicating a lateral fall onto the greater trochanter, the ultimate load
of the studied femora increased on average by 20.5%. Work to failure also increased
significantly but stiffness did not change. However, since this material would be resorbed
by the bone and disappear over time, its applicability to prevent osteoporotic fractures
in highly osteoporotic bones is questionable.
Besides experimental testing, computational work has also been applied in this field to
plan and analyse the effect of the femoral augmentation procedure. Basafa and Armand
(2013, 2014) used Finite Element Analysis (FEA) to optimise the PMMA volume and
distribution in 8 pairs of osteoporotic femora prior to the experiment. Numerically, using
on average 13.4ml of bone cement, an increase of 100% in the femur yield load could be
achieved. The cement distribution primarily depended on the material properties of each
bone, but in most femora the injection pattern was directed from the supero-anterior
aspect of the neck to the posterior zone of the greater trochanter. In order to perform
their experiments, this optimal distribution was converted into a feasible injection
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pattern (Basafa et al., 2015). Using 9.5ml of bone cement, the fracture load increased by
30% and the energy to failure by 124%. Using a similar strategy, Farvardin et al. (2019)
conducted a computational study highlighting the importance of preoperative planning
in femoral augmentation. Three generalized augmentation strategies were studied and
compared against a customised pattern based on matching spheroids to the optimal
distribution (Basafa and Armand, 2014). Using 9.2ml of bone cement, the customised
pattern resulted in a 79.6% yield load increase and 199% yield energy increase while the
generalized strategies reached a maximum of 32.7% and 139.9% yield load and yield
energy increase respectively. Based on the principles of bone remodelling, Varga et al.
(2017) designed an augmentation strategy that would protect the femur against a lateral
fall with approximately 12ml of bone cement. Nonlinear FE simulations were used to
evaluate the mechanical properties, and augmentation resulted in a 64% increase in the
yield force. Using FEA, Ramos-Infante and Pe´rez (2019) compared augmentations with
low viscosity and high viscosity bone cement. In their study, the elastic modulus of each
augmented element increased by a percentage, dependent on the element volume, bone
cement viscosity and minimum density associated with the femoral area where the
element is located (Ramos-Infante et al., 2018). This improvement factor was
determined to be approximately 37% for high viscosity bone cement and 224% for low
viscosity bone cement. Therefore, their results suggest that when using lower amounts
of bone cement (3ml), low viscosity bone cement led to a greater improvement in
fracture load (29% increase) than high viscosity (10% increase).
2.4.2 Augmentation Materials
Given the risks associated with femoral augmentation, a crucial aspect to consider is the
augmentation material. The desirable properties of bone cement for femoral
augmentation comprise ease of preparation and handling, suitable working and setting
time, and adequate viscosity. Another necessary characteristic is radiopacity, to allow
cement visibility in X-rays. Additionally, in order to avoid thermal necrosis and other
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potential side effects, the material should present a low curing temperature after
injection and not be toxic. After the curing process, the bone cement should have
mechanical properties that are adequate for withstanding the loads acting on a femur
during normal activities and low-impact falls. Ideally, bone cement should be
osteoinductive (promote bone formation) and osteoconductive (promote bone apposition
along its surface). It is also essential that it is biocompatible and non-resorbable. The
main types of injectable bone cements are Acrylic Bone Cements (ABCs), Calcium
Phosphate Cements (CPCs), Glass Polyalkenoate Cements (GPCs) and Composite
materials.
• Acrylic Bone Cements (ABCs)
Acrylic bone cements are composed of polymethyl methacrylate (PMMA) and methyl
methacrylate (MMA). In the compound, an activator-initiator and radiopaque agents are
also present. The mixing of the polymer powder with the liquid monomer forms a highly
viscous material that can be easily injected into bone cavities (Vazquez et al., 1998).
PMMA-based acrylic bone cement is a self-curing material that polymerises and solidifies
rapidly at room or body temperatures.
Despite a large number of PMMA bone cement brands being commercially available,
their compositions only vary slightly and have essentially remained unaltered over the
past 50 years. This is due to the good performance of PMMA in terms of biomechanical
strength, stiffness and ease of handling, the familiarity for orthopaedic surgeons and the
fact that it is a cost-effective solution (Lieberman et al., 2005). This type of bone
cement presents in vitro compressive strengths between 70 and 100MPa (Heini and
Berlemann, 2001). Given the characteristics of this material, it is expected that most
femoral augmentation experiments use commercial PMMA cement as the reinforcing
agent (Heini et al., 2004; Sutter et al., 2010a,b; Beckmann et al., 2011; Fliri et al., 2013;
Springorum et al., 2014; Basafa et al., 2015; Raas et al., 2016). However, although the
use of PMMA bone cements is widespread, they present several disadvantages.
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Depending on the amount of PMMA and the cement composition, the polymerisation
temperature can be higher than 65°C and cause thermal necrosis in the surrounding
tissues. Another concern is the monomer toxicity: MMA is not biocompatible and can
cause chemical necrosis in the surrounding tissues if polymerisation is incomplete (Feith,
1975; Albrektsson and Linder, 1984; Lu et al., 2002). Additionally, over exposure to its
fumes during mixing and injection may cause asthmatic reactions and/or lachrymation.
Also, PMMA bone cement is not osteoinductive or osteoconductive and does not
remodel. There is no chemical bonding between PMMA based cements and bone tissue;
loads are transmitted by contact and mechanical interlocking (Kinzl et al., 2012). Thus,
the fact that PMMA shrinks (from 2% to 6% in volume) due to polymerisation (Muller
et al., 2002) contributes to the development of gaps between the two materials and
residual stresses in the trabecular bone.
• Calcium Phosphate Cements (CPCs)
Calcium Phosphate Cements (CPCs) are produced by a chemical reaction between a
solid and a liquid phase which, when mixed, form a paste that progressively sets and
hardens into a solid mass (Zhang et al., 2014). The solid phase comprises one or several
calcium phosphate (CaP) compounds and the liquid phase is water or an aqueous
solution. The CPC reaction can generate two possible final products: brushite or apatite
(such as hydroxyapatite or calcium-deficient hydroxyapatite) (Bohner, 2007). In general,
apatite cements have higher strengths than brushite cements. Unlike PMMA based
cements, calcium phosphate cements are osteoconductive and progressively remodel with
time (Frankenburg et al., 1998; Larsson and Bauer, 2002). CPCs harden at body
temperature and do not produce a highly exothermic reaction, which increases the
possibility of incorporating drugs or biological molecules in the cement (Ginebra et al.,
2006, 2012; Verron et al., 2012). Additionally, CPCs do not shrink during the hardening
process, avoiding the generation of residual stresses in the trabecular tissue.
The handling characteristics of calcium phosphate cements also differ from those of
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PMMA. In general, CPCs need to be modified to reduce their setting time and improve
their cohesion and injectability (Bohner et al., 2006). CPCs with long setting times or
weak cohesion are not adequate for bone augmentation and can cause a number of
medical issues (Ueyama et al., 2001). Therefore, the composition and preparation of
CPCs are often altered in order to improve these properties but not compromise others
such as strength or fracture toughness. Further disadvantages of this type of cement are
their high cost and poor mechanical properties, with compressive strengths ranging from
0.34 to 80MPa depending on the powder composition (He et al., 2015). Additionally,
CPCs present brittle behaviour and low fracture toughness (Morgan et al., 1997;
Harmata et al., 2015) which makes them unsuitable for usage in load-bearing
applications. In addition, they can be resorbed and substituted by new bone, with a
resorption rate depending on their composition and microstructure.
• Glass polyalkenoate cements (GPCs)
Glass polyalkenoate cements (GPCs) are materials formed by the reaction of an acid
degradable alumino–silicate glass with an aqueous solution of polyalkenoic acid. As
bone cements, they have the advantages of setting without a significant heat generation,
adhering to the bone and presenting high compressive strengths of up to 200MPa (Higgs
et al., 2001; Boyd et al., 2008a). Due to these reasons, they have been used in dental
applications but the presence of aluminium (Al) in all commercial formulations has
restricted their use in orthopaedics (the release of the Al3+ ion causes defective bone
mineralization and is involved in the development of degenerative brain diseases (Polizzi
et al., 2002)).
Aluminium-free GPCs have been developed for consideration in skeletal applications
(Darling and Hill, 1994; Wren et al., 2008), based on calcium-zinc-silicate or
calcium-strontium-zinc-silicate glasses. Zinc has the ability to increase bone mass
(Ovesen et al., 2001) and is antibacterial (Boyd et al., 2006), but zinc-based GPCs
present either setting times that are too short or a considerable drop in strength
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(Clarkin et al., 2009). Recently, Magnesium has been included in Al-free GPCs in order
to improve their handling characteristics without deteriorating their strength (Khader
et al., 2018). However, Al-free GPCs for orthopaedic applications are still not widely
commercially available.
• Composite Materials
Composite materials like Cortoss® (Orthovita, Malvern, USA) are currently being studied
as alternatives to PMMA bone cements. Cortoss® is a glass-ceramic reinforced polymer
composite designed to mimic cortical bone. It is supplemented with different materials
to stimulate bone apposition along its surface, obtain a suitable viscosity and increase
radiopacity and strength (Erbe et al., 2001). In vitro tests have shown a compressive
strength between 91 and 179MPa (Boyd et al., 2008b) and a lower curing temperature than
that of conventional PMMA. This material has proven to be bioactive and biocompatible.
It also benefits from a higher degree of monomer conversion compared to PMMA bone
cements (Pomrink et al., 2003), decreasing the possibility of toxic MMA leakage.
Femoral augmentation may be considered in the future as treatment option for the
prevention of osteoporotic hip fractures. However, due the serious risks involved in the
treatment, further research must be carried to evaluate its safety before applying it in
vivo. Additionally, femoral strength improvement following augmentation is highly
dependent on bone cement location and volume, original bone material properties,
augmentation material and type of fall. Given all the sources of variability involved in
femoral augmentation, the use of computational models to study the procedure seems
more efficient than carrying experimental work. Therefore, it could be beneficial to use
such models to plan the femoral augmentation procedure, study its biomechanical effects
and evaluate its risks. Through the use of numerical simulations. the following chapters
explore the requirements of femoral augmentation, its side effects and its limitations.
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Heuristic Optimisation of Bone
Cement Volume and Placement in
Femoral Augmentation
3.1 Introduction
Femoral augmentation involves the mechanical reinforcement of osteoporotic femora using
an injectable bone cement, commonly PMMA. The biomechanical effect of this treatment
is patient-specific and related to the augmentation material, its volume and distribution
inside the femur. Additionally, side effects such as bone thermal necrosis and embolism
(Jefferiss et al., 1975; Belkoff et al., 2001; Geraci et al., 2013) are risks involved in the
procedure and are related to the injection of large volumes of bone cement. Therefore,
it is of importance to achieve the best possible compromise between maximising the
strength enhancement of the osteoporotic femur, through the injection of bone cement,
and minimising the side effects of the procedure. Finding the optimum bone cement
distribution through experiments would require a very large sample size, and it would
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not be possible to compare how different augmentation strategies affect the same femur.
Applying numerical optimisation techniques to computational models of the femur is a
more efficient approach that could provide valuable information.
The first objective in this chapter was to develop seven computational models of the
same femur with different osteoporotic levels. Numerically imposing several degrees of
osteoporosis to the model allows for direct comparison in results with respect to the
same bone morphology. The second objective was to calculate the yield load of the femur
models and compare them with existing experimental and computational data to evaluate
the model’s response. The third objective was to identify the optimum bone cement
volume and distribution required in those osteoporotic femora to achieve certain level
of reinforcement. Therefore, bone augmentation was stated as a topology optimisation
problem given a specific set of loads, boundary conditions and constraints related to
the mechanical strength of the augmented bone. The fourth objective was to identify
the correlation between level of osteoporosis and optimum volume of bone cement, as
the latter is proven to be an important factor both for the biomechanical properties of
bone after an augmentation procedure (Chevalier et al., 2008; Varga et al., 2017) and the
long-term behaviour of bone after augmentation (Badilatti et al., 2017).
3.2 Methods
3.2.1 Model Development
One inherent element to bone augmentation research is the fact that cadaveric
osteoporotic femora, based on which researchers develop their computational models,
are of varied morphology. Consequently, the respective conclusions are not always
directly comparable. For this reason, in experimental studies of femoral augmentation
the control group comprises of the non-augmented native contralateral femora (Heini
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et al., 2004; Beckmann et al., 2007; Sutter et al., 2010a,b; Beckmann et al., 2011; Fliri
et al., 2013). In this scenario, the ideal case would involve having a set of different bones
and, for each bone, its material properties for different T-Score levels (ranging from a
healthy condition to severe osteoporosis). As an attempt to mimic this ideal case and
for the needs of the present study, a healthy femur was used as a reference model and
different degrees of osteoporosis were virtually introduced by appropriately changing the
modulus of elasticity of the bone tissue. The advantage of this approach is that all
numerical results, related to a specific degree of osteoporosis, refer to the same bone and
allow direct comparison.
One femoral CT dataset was obtained from the OsiriX open access repository (available
at www.osirixviewer.com) and segmented using InVesalius 3.1 (CTI, Sao Paulo, Brazil).
The model was then imported to SolidWorks 2017 in order to obtain a 3D solid bone
model. This model was imported into ANSYS Mechanical APDL v.17.0 (Ansys Inc,
Pennsylvania, USA), where an unstructured mesh was generated using 4-node
tetrahedral elements. Inhomogeneous isotropic bone properties were mapped from the
CT images to the mesh using BoneMat v.3.1 software (available at
http://www.bonemat.org/). Typically, radiological density (ρQCT ) is obtained from the
CT calibration phantom. However, as no scanner calibration was available for the files
used in the present study, each Hounsfield Unit (HU) was converted into radiological
density (ρQCT ) using information from the images and the literature. In greater detail,
Equation 3.1 was used to convert HU into radiological density for the healthy tissue:
ρQCT (H) = 0.109 + 0.001086 ·HU (3.1)
This equation was derived by taking into account the range of the HU, as given by the
software InVesalius during the development of the model and supported by literature data
on material properties of typical healthy bone tissue. For the latter, a Young’s modulus
of 17GPa and 2.5GPa was considered for the cortical and trabecular tissue, respectively
(Falcinelli et al., 2014; Chen et al., 2015).
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In order to develop several osteoporotic femur models, the following relationship between
T-Score and BMD was defined according to the World Health Organization definition of
osteoporosis:
T − Score = BMDosteo − 1.020.144 (3.2)
Where BMDosteo stands for the Bone Mineral Density of an osteoporotic femur and the
normalisation has taken place with respect to a young, normal adult population (Bone
Mineral Density (BMD) of the femoral neck: 1.02g/cm2; Standard Deviation: 0.144g/cm2
(Looker et al., 2012)).
The values for BMDosteo were calculated by rearranging Equation 3.2 and selecting
discrete values for the T-Score. These values were then compared to the reference BMD
(i.e. 1.02g/cm2), yielding the reduction of the reference BMD. This percentage (referred
in this study as reduction factor δ) was used to virtually introduce osteoporosis in the
models. The elastic modulus of both the cortical and trabecular tissue were reduced by
the same percentage, which is representative of senile (Type 2) osteoporosis, especially
for men (Riggs et al., 1982; Khosla and Riggs, 2005). Table 3.1 summarizes, for a
predefined set of T-Scores, the respective values for BMDosteo and the reduction factor
δ.
Table 3.1: T-Score, BMD and BMD reduction applied to each femur
Osteopenia Osteoporosis
T-Score -1.0 -1.5 -2.0 -2.5 -3.0 -3.5
BMDosteo (g/cm2) 0.876 0.804 0.732 0.660 0.588 0.516
Reduction Factor δ 14% 21% 28% 35% 42% 49%
Therefore, for the six osteoporotic femur models (which cover the range from mild
osteopenia to severe osteoporosis), the radiological density ρQCT (O) was derived applying
a uniform reduction factor δ to ρQCT (H):
ρQCT (O) = 0.109δ + 0.001086δHU (3.3)
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After this, the radiological density (ρQCT (O)) was converted to ash density (ρash) according
to Schileo et al. (2008a):
ρash = 0.079 + 0.88 · ρQCT (O) (3.4)
Finally, the ash density (ρash) was converted into the modulus of elasticity using Equation
3.5 (Keller, 1994):
E = 10500 · ρ2.29ash (3.5)
For all elements, a Poisson’s ratio of 0.3 (Zhang et al., 2013) was assumed. Also, all
moduli of elasticity calculated using Equation 3.5 were grouped into intervals of width
100MPa. In this way, a controlled number of material properties groups were created
(Figure 3.1).
200                     2822                  5444                   8067                  106891511                   4133                  6756                   9378                  12000
(MPa)
Figure 3.1: Distribution of elastic modulus in a sagittal cross-section of a femur with T-Score
-2.5
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3.2.2 Load Case
Given that most osteoporotic hip fractures occur as the result of a lateral fall, boundary
conditions replicating a lateral fall onto the greater trochanter were applied to the femur
models. To this end, the femur was distally fully constrained, while the lateral side of the
greater trochanter was restricted to move only in one plane (Schileo et al., 2014). The
applied force was tilted by 10° in the transverse plane and 15° in the frontal plane and
was uniformly distributed over the medial nodes of the femoral head (Figure 3.2). Similar
sets of boundary conditions are commonly used in mechanical tests to replicate lateral
falls on the greater trochanter (Beckmann et al., 2007; Sutter et al., 2010a,b; Beckmann
et al., 2011; Fliri et al., 2013).
Fβ 
Fα 
(a) (b) 
β 
α 10°
15°
Figure 3.2: Lateral fall boundary conditions
3.2.3 Topology Optimisation
A unidirectional evolutionary scheme was developed to optimise the bone cement volume
and placement in the osteoporotic femur. This iterative algorithm concerns a two-level
nested conditional loop, where the outer loop controls the magnitude of the externally
applied load and the inner loop controls the number of failed elements.
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Initially, a small external load is applied and a linear Finite Element (FE) simulation of
a lateral fall on the greater trochanter is conducted (applying the boundary conditions
detailed in Section 3.2.2). Then, the maximum (εmax) and minimum (εmin) principal
strains of each element are computed. If these values are within the range of acceptable
strain values (less than 0.73% in tension and 1.04% in compression (Bayraktar et al.,
2004)), a new iteration of the outer loop begins with an increased external load (in steps
of 52.5N). Otherwise, the inner loop is activated, which calculates the percentage of failed
elements in the proximal femur. An element is considered failed if the aforementioned
strain constraint is violated. If the percentage of failed elements is equal or higher than 1
(Basafa and Armand, 2014), the yield load of the bone has been reached. The yield load
was calculated for the healthy femur and the six osteoporotic and osteopenic models.
When the yield load of the femur is reached, the material properties of the failed elements
are changed to the ones of PMMA bone cement (Young’s modulus: 2300MPa; Poisson’s
ratio: 0.3 (Kinzl et al., 2012; Lu et al., 2014)) and the total accumulated volume of bone
cement is updated. It is worth noting that in a femoral augmentation procedure, cement
is only injected in the trabecular bone, so elements that belong to the cortical will not
be replaced by bone cement and will remain intact. Besides, bone cement elements can
also fail if their maximum/minimum principal strains are above 0.2% both in tension and
compression. This nested loop is repeated until the target value for the external load is
reached. In this study, the target load was set to be 15% larger than the load capacity of
the reference healthy femur. The obtained accumulated volume of bone cement represents
the optimum volume of bone cement.
The algorithm was developed in ANSYS Parametric Design Language (APDL) and
applied to the six osteoporotic and osteopenic femur models. The pseudocode is
presented below:
Model Setup: Setup the model of the examined osteoporotic bone for a linear static
analysis and count the total number of elements (NELtotal) of the proximal femur.
Define the following parameters: Initial Load, Target Load, Load Step, Threshold
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Define Region of Interest (ROI): All elements used for the discretisation of the
trabecular tissue
Apply Initial Load: Applied Load = Initial Load
While (Applied Load < Target Load) Do
FE Linear Static Analysis
Count elements violating the strain constraints (NELfail)
Define: PERCfail = NELfail / NELtotal
While PERCfail > Threshold Do
Assign bone cement to NELfail elements in the ROI
Bone Cement Volume (BCV) = BCV + NELfail elements volume
End (PERCfail)
Applied Load = Applied Load + Load Step
End (Applied Load)
A mesh convergence analysis was performed to ensure reliability of obtained results. To
this end and for each one of the developed models, six meshes with different element
density (from approximately 38,500 to 432,000 DOFs) were studied under the same
loading conditions representing a lateral fall on the greater trochanter. The stiffness,
strain energy and optimum bone cement volume required to reach a predefined target
load were monitored.
3.3 Results
Results of the mesh convergence analysis for the osteoporotic femur with T-Score equal
to -2.5 is shown in Figure 3.3. The percentage difference between the results obtained
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with the reference mesh (finest mesh) and each one of the other meshes was plotted
against the Degrees of Freedom (DOF) of each mesh. Mesh convergence was achieved for
a discretisation using 501,1399 4-node tetrahedral elements (i.e. 270,792 DOF). It should
be noted that in all examined cases, the metrics for orthogonal quality and aspect ratio
were monitored and found to be similar and within an acceptable range across all used
meshes.
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Figure 3.3: Mesh convergence for a T-Score -2.5 femur
The yield load of the healthy femur was calculated as the necessary force to load 1%
of the tissue above the principal strain limits and was found to be 5513N. This was
also calculated for the rest of models and is plotted in Figure 3.4 according to their T-
Score. Results from previous computational (C) or experimental (E) studies that also
calculated the femur yield load (YL) or ultimate load (UL) under lateral fall conditions
are included in the chart for comparison purposes (corridors based on mean value and
Standard Deviation).
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Figure 3.4: Yield load comparison between the present study and previously published studies
The healthy bone yield load value increased by 15% was subsequently used as the target
load for the optimisation algorithm. Table 3.2 shows the bone cement volume needed to
restore the femur yield load for different levels of osteopenia and osteoporosis. The average
optimum bone cement volume was 5.24ml for osteopenic and 14.39ml for osteoporotic
femora. As expected, the required bone cement volume was larger in models with high
degree of osteoporosis.
Table 3.2: Evolutionary Structural Optimisation results
Osteopenia Osteoporosis
T-Score -1.0 -1.5 -2.0 -2.5 -3.0 -3.5
Original Yield Load (N) 4043 3518 3045 2625 2205 1805
Bone Cement Volume (ml) 2.98 4.75 7.99 10.84 14.24 18.09
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The final bone cement distribution for the three osteoporotic models is qualitatively
similar (Figure 3.5), requiring bone cement in the greater trochanter, superior area of
the femoral neck and ring around the femoral neck. Femur models with low degree of
osteoporosis required the largest amount of bone cement in the greater trochanter
region.
T-Score -1.5
T-Score -2.0 T-Score -2.5
T-Score -3.0 T-Score -3.5
T-Score -1.0
Figure 3.5: Final bone cement distribution for the six developed models
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Figure 3.6 illustrates the evolution of failed elements and bone cement volume for the
model with T-Score -2.5. During the 88 iterations, the percentage of elements violating
the strain constraints exceeds 1% several times (Figure 3.6a). At this point, additional
bone cement is introduced in the proximal femur (Figure 3.6b) and the percentage of failed
elements is recomputed. Since the elements of the cortical tissue cannot be replaced with
bone cement, a small percentage of elements remain failed throughout each cycle despite
the continued augmentation.
Iteration
Iteration
Bo
ne
 C
em
en
t V
ol
um
e 
(m
l)
%
 F
ai
le
d 
El
em
en
ts
A
pp
lie
d 
Lo
ad
 (k
N
)
A
pp
lie
d 
Lo
ad
 (k
N
)
(b)
(a)
Figure 3.6: Iteration history of (a) % failed elements and (b) bone cement volume for the
femur with T-Score -2.5
38
CHAPTER 3
The progression of bone cement distribution through the evolutionary optimisation of
a reference model (T-Score -2.5) is illustrated in Figure 3.7. The algorithm initially
reinforced the greater trochanter, where the largest principal strains are located. Then,
the superior and inferior part of the femoral neck are augmented independently until they
merge forming an incomplete ring around the femoral neck.
Figure 3.7: Evolution of the bone cement placement for the femur with T-Score -2.5
3.4 Discussion
The yield load of the developed femur models was calculated in this study as part of
the topology optimisation algorithm and to achieve this, it was necessary to adopt a
yield criterion. Some studies use stress-based yield criterion like von Mises (Keyak et al.,
2001; Keyak and Falkinstein, 2003), while others agree that the Drucker-Prager criterion
is more suitable in FE models that simulate brittle materials like bone (Bessho et al.,
2007). Finally, some others propose that bone fracture is a strain-controlled mechanism
(Nalla et al., 2005; Va¨a¨na¨nen et al., 2013). In order to prove this, Schileo et al. (2008b)
performed a numerical-experimental study comparing a strain criterion with two different
stress criteria to determine the femur failure and yield load. Their results, in agreement
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with Yosibash et al. (2010) suggest that the failure load would be underestimated when
using von Mises or principal stress criteria. Therefore, the criteria adopted in this study
to predict the failure of the elements were principal strains, considering that bone reaches
its yield point at lower strains in tension than in compression (Bayraktar et al., 2004).
The predicted yield loads in this study due to a lateral fall on the greater trochanter
ranged from 1805N to 4042.5N (mean 2873N) depending on the femur T-Score.
For the development of the femur 3D models, a power law was used to relate elastic
modulus and ash density (Keller, 1994). This relationship was developed based on
uniaxial compression tests of human vertebral and femoral bones. Other relationships
have been proposed in the past (Carte and Hayes, 1977; Morgan et al., 2003), which
could affect the final elastic modulus distribution in the femur. Additionally,
osteoporosis was artificially introduced in these models in a homogeneous way. This is
representative of senile osteoporosis, where the bone mass loss of cortical and trabecular
tissue deteriorate at a similar rate (Riggs et al., 1982; Khosla and Riggs, 2005) but not
of postmenopausal osteoporosis, where the rate of loss of cortical bone mass is lower
than the rate of loss of trabecular bone mass (O’Flaherty, 2000). Because of the
aforementioned reasons, it was necessary to validate our yield load predictions with
results from the literature (Figure 3.4). Yield or fracture load predictions in previously
published studies are varied, as they depend on several factors such as the applied
boundary conditions, bone size and shape and material properties. Despite this, the
predicted yield loads for osteoporotic T-Scores (-2.5 to -3.5) in this study were in a
reasonable range and corresponded well with fracture load values obtained in studies
replicating a lateral fall by Sutter et al. (2010a,b); Falcinelli et al. (2014); Basafa and
Armand (2014). Since most studies are performed in osteoporotic models, the yield load
of osteopenic models (T-Score -1 to -2.5) was only compared against Weber et al.
(2014), limiting its validity. A good correlation was found between the two studies,
showing a similar load vs T-Score trend. The healthy femur yield load prediction
(5500N) was also similar to the healthy bone yield load found by Verhulp et al. (2008)
(5450N) using micro-FE meshes. Comparisons were performed against these studies
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because they replicate a fall onto the greater trochanter, with boundary conditions or
experimental settings that are similar to the ones applied in the present chapter.
Linear static analyses were conducted to find the femur yield load in order to avoid
the complexities related to the simulation of a dynamic event (such as modelling the
material properties of bone at high strain rates). A large number of experimental studies
of femoral augmentation have been performed using quasi-static tests (load applied at
2mm/s) to determine the augmented and non-augmented femur fracture load (Heini et al.,
2004; Beckmann et al., 2007, 2011; van der Steenhoven et al., 2009; Steenhoven et al.,
2011; Springorum et al., 2014; Raas et al., 2016). Hence, despite they do not represent
accurately the behaviour of bone during an impact, static simulations were considered
acceptable to determine augmented and non-augmented yield load and compare with the
aforementioned quasi-static tests.
Finding the yield load of the developed models was only part of the optimisation procedure
presented in this chapter, that was developed based on the idea of the ESO method
presented by Xie and Steven (1996). With the algorithm, the optimum bone cement
volume and placement was computed for femora with different levels of osteoporosis and
osteopenia. Results suggest that on average, 5.24ml of PMMA for osteopenic and 14.39ml
for osteoporotic femora can restore the yield load of the femur models. For the osteoporotic
femora, the bone cement pattern generated inside the bone by the optimiser involved
augmenting the greater trochanter and creating an incomplete ring of cement around
the femoral neck. This PMMA distribution is similar to the one obtained by Basafa
and Armand (2013, 2014) when applying their BESO strategy. In their investigation,
values ranging from 5.6ml to 26.2ml of PMMA were necessary to obtain an increase
of 100% in the femur yield load depending on the size, shape and material properties
of each osteoporotic femur. The average T-Score of the osteoporotic femora studied in
their research was -3.53 and their pre-augmentation yield load ranged from 1485N to
3905N. The femora with similar yield load to that of the present research (T-Score -3.5,
1805±500N) were selected for comparison, and required on average 9.36ml of bone cement
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to double their yield load. In this current study, 6.21ml of bone cement were necessary to
increase the yield load of the T-Score -3.5 femur by 100%. This value can be extrapolated
from the iteration history of the optimisation method. Comparing the method presented
in the aforementioned research with the one of this study, some significant differences
arise. Firstly, the method presented in this chapter is a unidirectional ESO that uses
principal strain values as the optimisation criterion, while Basafa and Armand (2013,
2014) applied a Bidirectional ESO and considered strain energy density. Moreover, in
the proposed algorithm the applied load increases by a constant value (52.5N) at each
iteration, while Basafa and Armand (2013, 2014) applied a constant load and scaled the
strains assuming linearity.
Other computational studies have been developed recently, focusing on bone cement
distributions that, as opposed to the ones presented in this chapter, are easy to inject in
practice. Varga et al. (2017) studied five different augmentation strategies and
attempted to find the most advantageous one through numerical simulations. They
concluded that approximately 12ml of PMMA can result in an average increase of 64%
in the femur yield load when augmenting with a cylinder from the greater trochanter to
the end of the femoral head. In contrast to this generalised approach to femoral
augmentation, Farvardin et al. (2019) reported that subject-specific planning of
femoroplasty can result in a 79.6% yield load increase using 9.2ml of bone cement. In a
more recent study, Ramos-Infante and Pe´rez (2019) reduced bone cement injection to
only 3ml in the weakest locations of the femur, leading to a 29% increase in the yield
load. Interpolating our results to obtain the yield load increase reported by the
aforementioned studies shows that 5ml of bone cement would be required to obtain a
64% increase in the yield load, 6ml to obtain a 79.6% increase and 2ml to obtain a 29%
increase. This shows that the ideal bone cement distribution presented in this chapter is
more effective at improving the bone strength, although this is expected due to the use
of realistic bone cement geometries in their studies. Therefore, it is still unclear if
adapting the ideal bone cement distributions presented in this chapter to become
feasible augmentation strategies will lead to better results than the ones of the
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previously mentioned studies or not.
Several parameters in the applied optimisation method could be changed in order to adapt
it to different needs. One of these parameters is the target load, which in the present work
was set to be 15% larger than the yield load of the healthy femur. However, the optimiser
provides sufficient versatility to allow a target load of any desired value and finding the
optimum cement volume and distribution for partial restoration of bone properties could
also be an application of this algorithm. Furthermore, the reported predictions were made
considering that the femur yield load was achieved if 1% of the elements of the proximal
femur were above the strain limit values. This value was also adopted by Pistoia et al.
(2002); Basafa and Armand (2014). However, different approaches have been presented
in the literature as in the case of Falcinelli et al. (2014) who averaged the principal strains
on a circle of 3mm radius and Yosibash et al. (2010), who focused their analysis on the
10 elements most susceptible to failure. Results of both yield load and optimum bone
cement volume are susceptible to change if different criteria are adopted. However, since
the values chosen in this chapter have been used in the past in experimentally validated
studies, they were considered appropriate for the simulations.
In this chapter, six osteoporotic and one healthy model were developed. Their yield load
under lateral fall conditions were calculated and compared against existing experimental
and computational data, showing a good agreement. After this, a topology optimisation
algorithm was applied to each model in order to find the ideal distribution of bone cement
in the femur that would protect them against a lateral fall. To achieve this, specific
simplifications were applied. The time-dependent bone cement injection process was not
simulated, nor was the solidification of the injected bone cement. Consequently, the
influence of the gravitational field on the liquid state of the bone cement as well as partial
filling of voids and shrinkage of the bone cement after solidification were not considered.
Additionally, given that bone cement is embedded in trabecular tissue, assuming that
bone tissue can be directly replaced by bone cement is not physiologically realistic. The
distribution of elastic modulus in the osteoporotic models should affect the behaviour
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of the augmentation material, which is a limitation addressed in Chapter 4. Another
simplification of this study concerns the assumption that bone cement may be injected
independently and separately into any location. In theory, that might be achieved through
minimally invasive surgical techniques and miniaturization (Bergeles et al., 2015; Gultepe
et al., 2015) but, to the best knowledge of the author, this has not yet been applied in
femoroplasty. For this reason, feasible injection strategies will be studied in Chapter 5.
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Effect of Bone Cement Porosity on
Femoral Augmentation
4.1 Introduction
Computational studies such as the one presented in Chapter 3 have been conducted to
minimise the required amount of bone cement and optimise the injection locations while
providing a significant net benefit to femoral mechanical properties (Basafa and Armand,
2014; Varga et al., 2017). However, results from numerical simulations depend on a variety
of factors such as the bone morphology, the degree of osteoporosis, the imposed boundary
conditions and the material properties of the augmented bone (Rohlmann et al., 2010;
Wijayathunga et al., 2013). The bone geometry, degree of osteoporosis and the respective
material properties are often obtained from a CT scan. Similarly, the most commonly
used boundary conditions in the experimental and computational study of femoroplasty
replicate a lateral fall on the greater trochanter (Sutter et al., 2010a,b; Beckmann et al.,
2011; Fliri et al., 2013; Springorum et al., 2014; Basafa and Armand, 2014; Basafa et al.,
2015; Varga et al., 2017), although different fall directions have not been compared. While
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all these factors remain significant topics of ongoing computational analysis research, the
present chapter is focused on two of them: the material properties of the augmented bone
and the direction of the fall.
Some studies consider the material properties of augmented bone as those of pure PMMA
without any porosity (Basafa and Armand, 2014), while other studies make use of the
concept of PMMA porosity (Varga et al., 2017; Kinzl et al., 2012). The mixing and
injection technique, as well as the shrinkage of the cement contribute to the porosity in
the solidified cement. More complex schemes have also been proposed, including PMMA
porosity, bone volume fraction and change of PMMA material properties with temperature
(Soyka et al., 2016). Consequently, the first objective is to determine whether PMMA
porosity has a statistically important impact when predicting the optimal volume of bone
cement required to achieve a specific level of bone augmentation. Additionally, the second
objective is to compare different approaches used to model the modulus of elasticity of
augmented bone. Finally, the importance of fall direction in the femur fracture load
has been previously studied (Pinilla et al., 1996; Falcinelli et al., 2014), but not applied
to determine bone cement requirements in femoral augmentation. Therefore, the third
objective is to quantify the sensitivity of the optimum volume of bone cement on two
essential design variables of the examined problem, namely grade of porosity of PMMA
and direction of the external load, which resembles variations of the fall direction.
4.2 Methods
4.2.1 Modelling the Material Properties of Augmented Regions
The six osteoporotic models developed in Section 3.2.1 were used throughout the analyses
performed in this chapter. In these models, ash density was calculated for each mesh
element from the femur CT scan. The ratio between ash density (ρash) and apparent
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density (ρapp) was considered to be constant and equal to 0.6. Therefore, the Bone
Volume Fraction (BVF) per element, defined as the ratio of the Bone Volume (BV) over
the Total Volume (TV), is equal to:
BV F = ρapp
ρtissue
(4.1)
Where the density of bone tissue (ρtissue) was considered to be equal to 1.81g/cm3
(Nazarian et al., 2008).
The optimum volume of bone cement and its distribution within the femur was computed
for each model following the optimisation algorithm presented in Chapter 3, but the
material properties of the augmented regions were modelled following the five different
approaches shown below:
A. Pure PMMA (EPMMA = 2300MPa) according to Lu et al. (2014).
B. Pure PMMA considering cement porosity as per Equation 4.2 and according to
Kinzl et al. (2013).
EPOROUS−PMMA = EPMMA − (kE · pv) (4.2)
Where EPMMA is the elastic modulus of pure PMMA (2300MPa), kE is the decreasing
constant (6314MPa) and pv is the pore volume fraction (10%).
C. Bone cement composite applying the Voigt-Reuss-Hill average based on the Bone
Volume Fraction (BVF). The composite elastic modulus ECOMP was computed
(Equation 4.3) as the average of the Voigt upper bound EV (Equation 4.4) and the
Reuss lower bound ER (Equation 4.5).
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ECOMP =
EV + ER
2 (4.3)
EV = EBONE ·BV F + EPMMA · (1−BV F ) (4.4)
ER =
(
BV F
EBONE
+ 1−BV F
EPMMA
)−1
(4.5)
The Voigt bound yields from an isostrain consideration and the application of a rule of
mixtures to the stiffness of the involved materials, while the Reuss bound yields from an
isostress consideration and the application of a rule of mixtures to the compliance of the
involved phases.
D. Bone cement composite applying the Voigt-Reuss-Hill average (Equation 4.3) but
replacing the elastic modulus of pure PMMA (EPMMA) in Equations 4.4 and 4.5
with the elastic modulus of pure PMMA including cement porosity EPOROUS−PMMA,
as per Equation 4.2.
EPOROUS−COMP =
EV−POR + ER−POR
2 (4.6)
EV−POR = EBONE ·BV F + EPOROUS−PMMA · (1−BV F ) (4.7)
ER−POR =
(
BV F
EBONE
+ 1−BV F
EPOROUS−PMMA
)−1
(4.8)
E. Bone cement composite considering only the Voigt bound (Equation 4.4) but
neglecting the material properties of bone tissue (EBONE = 0) in the respective
rule of mixtures, as shown in Equation 4.9.
EV−PMMA = EPMMA · (1−BV F ) (4.9)
The difference between methods A and B is the elastic modulus of PMMA, which is
reduced by a constant in approach B. Method A was applied in Chapter 3 to compute the
optimum bone cement volume and placement but to the best knowledge of the author,
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the application of approaches C, D and E in femoral augmentation were firstly introduced
in this chapter.
The five defined modelling approaches for the modulus of elasticity of the bone cement
composite were investigated for six different levels of virtual osteoporosis, totalling 30
different cases. In all cases, bone cement was considered as a homogeneous and isotropic
material, with Poisson’s ratio equal to 0.3. It is worth clarifying that the available void per
element (V(ELE/PMMA)) that could be filled-in by bone cement was computed according
to Equation 4.10, where the element-specific BVF value is provided by Equation 4.1 and
the total element volume (V(ELE/TOTAL)) is retrieved from the mesh:
V(ELE/PMMA) = (1−BV F ) · V(ELE/TOTAL) (4.10)
Based on these 30 cases, a one-way Analysis of Covariance (ANCOVA), using the
software package SPSS Statistics v.17 (IBM Corporation, USA) was conducted to
investigate whether the different five modelling approaches provided results significantly
different to each other. To this end, within the SPSS environment, a post hoc
Bonferroni test was used to compare the influence of the different factors. For the
statistical analysis, values of p<0.05 were considered to be statistically significant.
4.2.2 Impact of Design Variables on the Optimum Volume of
Bone Cement
A sensitivity analysis was conducted using ANSYS Mechanical APDL in order to
investigate the sensitivity of the optimum volume of bone cement with respect to 3
design variables, namely the frontal and transverse direction of the applied load (Figure
4.1), and the bone cement porosity. In total, 1452 FEA were performed in a femur with
T-Score -2.5, based on all the combinations of the three parameters shown in Table 4.1
(α can have 11 different values, β can have 11 different values and pv can have 12
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different values).
Fβ 
Fα 
(a) (b) 
β 
α 
Figure 4.1: Direction of the applied load: transverse (α) and frontal (β).
Table 4.1: Input parameters, step size and range for the sensitivity analysis
Input parameter Step size Minimum Maximum
Transverse load direction (α) 2.5° 0° 25°
Frontal load direction (β) 2.5° 0° 25°
Pore volume fraction (pv) 2% 0% 22%
4.3 Results
The optimum volume of bone cement is plotted against the respective T-Score for all the
modelling approaches in Figure 4.2, showing that in order to reach the same target load,
the required PMMA volume increased with the degree of osteoporosis. This is anticipated
due to the femur yield load reduction as the degree of osteoporosis increases. Both the
mean value and the standard deviation increased as the degree of osteoporosis increased,
ranging from 3ml (SD=0.017) to 19.62ml (SD=2.25), as shown in Table 4.2. For femora
with a T-Score between -1.5 and -3.0, the Coefficient of Variation (CV) for the optimum
50
CHAPTER 4
volume of bone cement remains within the interval 13.53% - 14.61%. Additionally, Figure
4.2 shows that regardless the modelling method for estimating the modulus of elasticity
of the augmented bone, there is a strong linear correlation between the T-Score and the
optimum volume of bone cement (R2 > 0.9721 in all cases). It is because of this strong
linear correlation that an ANCOVA was applicable.
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Figure 4.2: Degree of osteoporosis vs optimum bone cement volume for the different modelling
approaches, including trend lines and correlation coefficient.
The ANCOVA test conducted across the modelling techniques defined in Section 4.2.1
evidenced no relevant differences between the pure PMMA approach and the rule of
mixture when bone cement porosity is not considered (pair A-C, p=1). The same
applied when bone cement porosity is considered (pair B-D, p=0.137). However,
statistically significant differences appeared between techniques A-B (p=0.048), A-E
(p=0.027), C-B (p=0.001) and C-E (p=0.001). This indicates that modelling without
porosity is statistically different to neglecting bone tissue or modelling with pure PMMA
and porosity. However, the ANCOVA test also showed that there was one modelling
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Table 4.2: Optimum volume of bone cement for the different modelling approaches and grades
of osteoporosis.
Osteopenia Osteoporosis
T-Score -1.0 -1.5 -2.0 -2.5 -3.0 -3.5
(A) Pure PMMA 2.98 4.75 7.99 10.84 14.24 18.09
(B) Pure PMMA + porosity 3.01 6.25 9.53 12.33 17.33 21.97
(C) Rule of mixture 3.00 4.75 6.62 9.57 12.81 16.89
(D) Rule of mixture + porosity 2.99 4.72 7.99 11.19 14.32 19.34
(E) Neglect bone tissue 3.03 6.04 8.98 13.69 17.73 21.83
Mean value 3.00 5.30 8.23 11.52 15.29 19.62
Standard Deviation 0.02 0.77 1.12 1.56 2.14 2.25
Coefficient of Variation (%) 0.6% 14.6% 13.6% 13.5% 14.0% 11.5%
approach, i.e. the newly introduced approach D (rule of mixture considering porous
PMMA) for which there was no statistically significant difference against any of the
other examined modelling methods. For this reason, approach D will be used as the
preferable modelling technique in this research. It is also highlighted that the
approaches A and B, which were found to be significantly different to each other, are two
approaches widely used in the literature (Basafa and Armand, 2014; Varga et al., 2017).
The aforementioned statistical findings are shown in Figure 4.3, where the five modelling
approaches are plotted as vertical bars, the height of which denotes the respective optimum
volume of bone cement. Bars with the same letter at their top correspond to modelling
approaches which were found not to be significantly different to each other. Noted that for
approach D there are two letters, where W indicates similarity between approach D and
approaches A and C, while X indicates similarity between approach D and approaches B
and E. Approaches A,C are statistically different to approaches B,E.
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Figure 4.3: Effect of the modelling approach on the final bone cement volume. Means with
different letters (W, X) are significantly different (Bonferroni procedure, p<0.05).
The optimum distributions of bone cement for one of the models (T-Score -2.5) are
depicted in Figure 4.4. Despite the different modelling approaches, bone cement
placement is very similar in all cases: reinforcing the femoral neck, superior part of the
proximal femur and greater trochanter.
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Figure 4.4: Bone cement volume in a femur with T-Score -2.5 and for the five different
modelling approaches (A to E).
Figure 4.5 shows the upper and lower bounds of the rule of mixture applied in approaches
C and D. It can be seen that when porosity is not considered (case C, Figure 4.5(a)),
the maximum difference between the two bounds is approximately 8.5%, found for a T-
Score of -3.5. However, when porosity is considered (case D, case C, Figure 4.5(b)), the
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maximum difference occurs in the femur with a T-Score of -1.0, and it is approximately
15%. Therefore, for approach D, the effect of bone cement porosity yields in Voigt and
Reuss bounds becoming more distinctive. For case C and up to a T-Score of -2.0, the
composite elastic modulus increases as the BVF increases, while for case D this observation
holds up to a T-Score of -2.5.
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Figure 4.5: Voigt and Reuss bounds for cases C (a) and D (b) and for different values of bone
volume fraction. Dark colour represents Voigt bound and light colour represents Reuss bound.
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Figure 4.6 shows the optimum volume of bone cement for all combinations of the input
parameters, namely the frontal angle, the transverse angle and the bone cement porosity,
when approach D is implemented. The PMMA volume increases when any of the three
inputs increases. This effect is more significant when the frontal angle increases than
when the transverse angle increases and therefore, more reinforcement would be required
to prevent a fracture if a fall were to occur under conditions characterised by high rotation
in the frontal plane.
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Figure 4.6: Contours of required PMMA volume for the combination of all the input
parameters: frontal angle, transverse angle and bone cement porosity.
The porosity of PMMA also influences the distribution of the optimisation results, as
Figure 4.7 illustrates. This figure shows the relative frequency distribution of the optimum
volumes from the 1452 examined combinations. In total, eight classes were used of width
equal to 2 and ranging from [6,8) up to and including [20,22]. For porosity levels up
to 4%, almost 50% of the combinations of frontal and transverse angles would require a
volume of bone cement within the class of (8, 10]. For porosity levels up to 8%, there
is one class (i.e. ([8,10)) which prevails with a relative frequency of at least 40%. For
porosity levels between 10% and 16%, the relative distribution becomes more uniform
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with a decreasing maximum peak value per class, as the porosity increases. For porosity
levels between 18%-22%, the class [14,16) clearly prevails over the other classes, with a
relative frequency of 35%, while the second highest relative frequency is at least 10%
lower. Lastly, no strong linear correlation was found between any of the three design
variables and the optimum volume of bone cement.
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Figure 4.7: Distribution of bone cement volume (relative frequency) for each level of porosity.
4.4 Discussion
The first research question that this chapter aimed to address was whether the bone
cement porosity has a statistically significant impact on the prediction of the optimal
bone cement volume required to achieve a specific level of augmentation. In Chapter 3,
the volume of bone cement was considered to be numerically equal to the volume of a
finite element which represents augmented bone (Basafa and Armand, 2014; Varga et al.,
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2017). This is not always a valid assumption, as injected bone cement may only fill-in
voids and not replace existing bone tissue. To overcome this problem, a more accurate
approach to determine the bone cement volume that is embedded in trabecular tissue
based the bone volume fraction was used in this chapter. However, in order to perform
femoral augmentation in practice it is necessary to pre-drill a channel in the bone, which
will eventually only be filled with bone cement. Therefore, once the length and radius of
the channel(s) are known, the bone volume fraction of the channel(s) elements should be
set to zero to accurately compute the required bone cement volume.
Five different approaches were used to model the modulus of elasticity of the bone cement
composite. Approach A was applied in Chapter 3 and considered that cemented elements
had the material properties of pure PMMA, as presented by Basafa and Armand (2014).
For different levels of osteoporosis and osteopenia, the required bone cement volume
varied from approximately 3 to 18ml (mean 9.82ml, SD=5.74). Given that the goal of the
optimisation was to increase the yield load of the different femora to a predefined target
load, the range of required bone cement volume is wide and highly dependent on the degree
of osteoporosis. Using approach, A, it has been reported (Basafa and Armand, 2014) that
for an increase of 100% in the osteoporotic femur yield load (T-Score -3.53) volumes
between 5.6ml and 26.2ml of bone cement were needed. Following the same method, a
recent numerical study with four femur models of average T-Score -3.2 (Farvardin et al.,
2019) showed a 79.6% average yield load increase with 9.2ml of bone cement. Using the
modelling approach proposed in case A for a femur with T-Score -3.5, 6.21ml of bone
cement were required to double the yield load. Results of the present study align with
those of Basafa and Armand (2014) regarding bone cement placement, i.e. superior part
of the femoral neck and greater trochanter. Varga et al. (2017) considered homogeneous
material properties for all the cemented elements and assumed 10% pore volume fraction
for the PMMA (similar to case B). In their study, after performing several non-linear
FE analyses placing a cylinder of bone cement in different locations they concluded that
approximately 12ml of PMMA result in an average increase of 64% in the femur yield
load. Following the approach presented in case B, using the average from all femur models,
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approximately 9.6ml of bone cement would be necessary to increase the yield force by 64%,
suggesting a more efficient placement of bone cement. However, as discussed in Chapter
3 this is may be due to the use of unrealistic augmentation patterns in the bone.
No statistically significant differences were found between cases A-C or B-D, which
indicates that using a rule of mixtures did not affect the optimisation result. However,
significant differences arise when introducing bone cement porosity (pairs A-B and B-C).
This is in agreement with Kinzl et al. (2011), who demonstrated that mechanical
properties of augmented tissue (in vertebroplasty) depend mainly on the bone cement
porosity and material properties. Despite constant porosity was assumed in this chapter,
additional factors such as bone damage due to shrinkage or detailed behaviour at the
bone-PMMA interface have been proposed to simulate augmented vertebrae (Kinzl
et al., 2012) on micro-FE models. The inclusion of those elements could help develop a
more accurate representation of the bone cement composite in the framework of femoral
augmentation, but would also increase the computational cost of the simulations.
Despite the statistically significant differences between some of the presented modelling
approaches, when bringing the problem to a practical scenario, it is necessary to
contextualise these differences. The maximum variation amongst the modelling
techniques occurred in the femur with T-Score -3.5 and was 5.1ml. In previous
experimental studies of femoral augmentation with PMMA, the reported injected
volumes of bone cement were between 9-18ml (Beckmann et al., 2011), 8-14ml (Varga
et al., 2016), 8-15ml (Springorum et al., 2014) and 11-15ml (Raas et al., 2016)
depending on the femur size and bone cement location. However, in other investigations
focused on the study of bone cement placement, the variation of injected PMMA in
different femora is much smaller, such as 15.2ml (SD=1.5) and 15.1ml (SD=1.6) (Sutter
et al., 2010a) and 9.5ml (SD=1.7) (Basafa et al., 2015). Hence, a variation of 5.1ml of
bone cement in the same femur is significant and may have an effect on the risks
involved in the augmentation procedure.
In this study, and for the cases C and D, the elastic modulus of augmented elements
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was computed using the Voigt-Reuss-Hill average as a function of bone volume fraction.
Given that the upper and lower bounds of the rule of mixture were sufficiently close, it
was not considered necessary to apply more complex formulations such as the Hashin-
Shtrikman. Case E aimed at investigating an extreme case where the bone tissue was so
deteriorated that it could be neglected. The long-term behaviour of the bone present in
the augmented region is unclear (Badilatti et al., 2017), so results obtained with method
E are a representation of one of the worst possible cases. It is also worth noticing the
similarity between approaches E (bone tissue is neglected) and B (pure porous PMMA).
In both cases the elastic modulus of the pure PMMA is reduced by a factor, controlled
either by the bone volume fraction or the porosity.
In the conducted sensitivity analysis, the required volume of bone cement was monitored
for various combinations of three design variables: frontal angle and transverse angle of
the applied load and bone cement porosity. Under lateral fall conditions, a reduction of
the femur yield load for high values of internal rotation (frontal angle) have been reported
by Bessho et al. (2009); Falcinelli et al. (2014); Zani et al. (2015); Pinilla et al. (1996).
This corroborates the findings of the conducted sensitivity analysis, since significantly
larger volumes of PMMA were required in cases with higher frontal angles due to the
reduction of the yield load. Results also show that the effect of increasing the transverse
load direction is not as significant. Both these findings are in accordance with the fact
that bone is capable of adapting to mechanical stimuli (Mullender and Huiskes, 1995)
such as loads occurring in normal body activities. Such loading conditions in the femur
usually comprise axial load and bending moment. This affects the femoral trabecular
architecture, which follows patterns suggesting the directions of principle compressive
and tensile stresses (Brand, 2011) and makes the bone more suitable to carry bending
than torsion (which occurs with high internal rotation).
The presence of porosity in the PMMA was modelled by reducing the elastic modulus
of the bone cement composite, which increases the necessary amount of PMMA to reach
certain augmentation level. For a low pore volume fraction, regardless the load direction,
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the optimum amount of bone cement for over 70% of cases was found to be between
8-12ml. However, when porosity is greater than 8% the maximum relative frequency of
optimum bone cement decreases to less than 40% and the histogram (Figure 4.7) becomes
more uniform. Hence, as the bone cement porosity increases, load direction becomes a
more significant factor in the optimisation result.
In this chapter, five different approaches were employed to calculate the elastic modulus
of the augmented bone, of which two are widely used in the literature. One of the
proposed schemes, which combined the Voigt-Reuss-Hill average with bone cement
porosity was the only one providing results that were not statistically different to the
rest of all other approaches and represented the most physiologically realistic case.
Furthermore, a strong linear correlation between the T-Score and the optimum volume
of bone cement required to restore the load capacity of the examined femora was
demonstrated. Lastly, the importance of the femur rotation in the frontal and transverse
plane in case of a lateral fall was quantified in terms of required bone cement volume to
avoid a fracture. Similar simplifications to the ones described in Chapter 3 apply to this
study, in addition to considering bone cement porosity constant and not modelling in
detail the bone-PMMA interface. Despite the results of the present chapter may be
useful to identify the weakest locations of the femur under lateral fall conditions and the
importance of bone cement porosity, they do not provide any solutions that are directly
applicable in the planning of femoral augmentation. For this reason, the outcomes of
this chapter will be used as a starting point in Chapter 5 to propose and optimise
several augmentation strategies that can be executed in real life.
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Study of Generalised, Feasible Bone
Cement Distributions
5.1 Introduction
The primary objective of femoral augmentation is to increase bone strength to a level
that significantly reduces the risk of suffering a fracture spontaneously or due to a
low-energy fall. Optimisation studies such as the one presented in Chapter 3 have been
conducted towards the joint aims of increasing femur strength and minimising the bone
cement volume (Basafa and Armand, 2013). In these studies, the bone cement optimum
distribution is patient-specific and generally has a complex shape that is not easily
achievable in practice. These customised treatments would require detailed preoperative
planning and equipment that is not widely available. Additionally, due to the
architecture of trabecular bone tissue it is not realistic to assume such complex injection
strategies could be executed without error. A further limitation is the need for
pre-drilled channels to inject the bone cement, as well as the limitation in the number of
channels that can be drilled before excessively damaging the cortical bone (Beckmann
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et al., 2011). Furthermore, during the injection, PMMA bone cement spreads irregularly
inside the bone and during the solidification process it generates an exothermic reaction
and shrinks (Muller et al., 2002; Gilbert, 2006).
Due to the aforementioned limitations, a more generalised approach with realistic
injection patterns could be beneficial for the procedure. To this end, Basafa et al. (2015)
proposed an augmentation strategy which matched three spheroids to the
patient-specific optimum bone cement distribution. Therefore, bone cement was injected
in the bone in three separate injections, requiring a navigation system to control each
injection location. An alternate augmentation approach was defined by Varga et al.
(2017) based on the principles of Wolff’s law. In their study, bone cement was placed in
a cylindrical channel from the greater trochanter to the femoral head and five different
injection strategies were tested by modifying the location of the cylinders. This strategy,
injecting bone cement in a previously drilled channel is the most common augmentation
method in experimental studies (Beckmann et al., 2011; Steenhoven et al., 2011, 2012;
Springorum et al., 2014). All these studies agree that the location of bone cement is
highly influential in the augmentation result, although the effect of minor variations in
the bone cement placement remains unclear.
In the past, femoral augmentation methods have been divided in to two main categories:
injecting bone cement as spheroids in different locations or drilling a path and filling it with
bone cement. Hence, one research question that this chapter aims to address is to what
extent these different augmentation techniques affect the augmented femoral strength. To
do so, six feasible distributions were proposed and studied based on the optimum bone
cement distribution found in Chapter 4. These feasible distributions considered certain
limitations of the femoral augmentation procedure such as the radius of the pre-drilled
path or the maximum number of paths that can be drilled. A second research topic is to
quantify the effect that different parameters in each distribution have on the augmented
yield load. Therefore, a sensitivity analysis using the Taguchi method and an ANOVA
analysis to determine the most influencing factors were performed for each distribution.
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Finally, the third research question is to identify the optimum placement and volume of the
proposed distributions which maximise the yield load after augmentation and minimise
the bone cement volume. To this end, a multiobjective optimisation was performed using
the patternsearch algorithm.
5.2 Methods
5.2.1 Feasible Bone Cement Distributions
The optimum and ideal distribution of bone cement inside an osteoporotic femur was
found in Chapter 4 using the heuristic optimisation algorithm presented in Chapter 3 and
considering the augmented regions as a composite formed of bone and porous PMMA.
After this, the next step is to transform the identified volume into a distribution of
bone cement that could be easily reproduced in practice. To this aim, two different
augmentation strategies were explored in this chapter: placing spheres of bone cement in
specific locations and placing bone cement into cylindrical drilled channels. These two
types of augmentation are feasible to inject in practice, have been previously tested in
experimental studies and are able to create bone cement distributions similar to the ideal
one. The ideal distribution of bone cement for a femur with T-Score -2.5 was divided in
four regions (Figure 5.1) and the centroids of these regions were used as reference points.
These points were A, B, C, D and CD, which is the centroid of the regions C and D
combined (Figure 5.1).
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Figure 5.1: Centroids of regions in which the ideal bone cement distribution was divided.
The proposed distributions are the following:
a. Spheres of bone cement
1. Three spheres located in a straight line: centroids of the spheres were
located at point A, CD and the midpoint of the line joining those points.
2. Three spheres located in a curve: centroids of the spheres were located at
point A, B and D.
b. Channels filled with bone cement
1. One straight drilled channel: straight line from point A to CD.
2. Two straight drilled channels: one straight line from point A to C and one
straight line from point A to D.
3. One curved drilled channel: arc passing through points A, B, CD.
4. Two curved drilled channels: one arc passing through points A, B, C and
one arc passing through points A, B, D.
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In all cases, the paths were extended laterally from point A until they reached the cortical
bone. In order to investigate the effect of different volumes of bone cement, three different
sphere radiii (5mm, 7mm, 9mm) and channel radii (3mm, 4mm, 5mm) were studied for
each distribution. One FE analysis was conducted for each case to calculate the increase in
the femur yield load after augmentation. To calculate the femur yield force, an initial small
load was applied and increased gradually until 1% of the elements in the proximal femur
failed, using boundary conditions that replicated a lateral fall onto the greater trochanter
(as described in Section 3.2.2). Analyses were conducted in ANSYS Mechanical APDL.
5.2.2 Sensitivity Analysis Using the Taguchi Method
For each one of the distributions presented in Section 5.2.1, a sensitivity analysis was
performed using the Taguchi orthogonal array. With this, the influence of each parameter
in the different distributions could be determined while considering the variation of the
remaining variables. The following design parameters were studied:
a. Spheres of bone cement
1. Three spheres located in a straight line: Taguchi L27 orthogonal array
(27 runs of FEA). Three levels were studied for the radius of each sphere (Ri
for i = 1, 2, 3) and centroid of spheres 1 and 3 (PXi, PYi, PZi for i = 1, 3).
Sphere 2 was located at the midpoint of the line joining these points.
2. Three spheres located in a curve: Taguchi L27 orthogonal array (27 runs of
FEA). Three levels were studied for the radius of each sphere (Ri for i = 1, 2, 3)
and centroid of each sphere (PXi, PY i, PZi for i = 1, 2, 3).
In the cases explained above, the sphere radius varied from 5mm to 9mm and the
centroid of each sphere varied ±10mm from the region centroid location.
b. Channels filled with bone cement
65
CHAPTER 5
1. One straight drilled channel: Taguchi L54 orthogonal array (54 runs of
FEA). Two levels were studied for the radius of the channel (R) and three
levels for the location of the line start and end points (PXi, PYi, PZi for
i = 1, 2).
2. Two straight drilled channels: Taguchi L54 orthogonal array (54 runs of
FEA). Two levels were studied for the radius of the first channel and three
levels for the radius of the second channel (Rj for j = m,n). Three levels were
studied for the location of each line start and end points (PXij, PYij, PZij for
i = 1, 2 and j = m,n).
3. One curved drilled channel: Taguchi L54 orthogonal array (54 runs of
FEA). Two levels were studied for the radius of the channel (R) and three
levels for the length of the arc (L) and location of the three points defining the
circular curve (PXi, PYi, PZi for i = 1, 2, 3).
4. Two curved drilled channels: Taguchi L54 orthogonal array (54 runs of
FEA). Two levels were studied for the radius of the first channel and three
levels for the radius of the second channel (Rj for j = m,n). Three levels
were studied for the length of each arc (Lj for j = m,n) and location of the
three points defining each circular curve (PXij, PYij, PZij for i = 1, 2, 3 and
j = m,n).
In the cases described above, the channel radius varied from 3mm to 5mm, the channel
length varied from 50mm to 150mm and the points varied±10mm from the region centroid
location.
For each distribution, a FE analysis was conducted to find the femur yield load after
augmentation. Given that the objective was to find the parameters that maximise the
percentage increase in the femur yield load, results were analysed using the larger-the-
better Signal to Noise (S/N) ratio. The S/N ratio (measured in dB) was calculated
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according to Equation 5.1.
S
N
= −10log 1
y2i
(5.1)
Where yi is the value of the yield load obtained from each simulation. After this, an
analysis of the variance (ANOVA) was performed to investigate the significance of each
parameter in the augmented femur yield load for each case. To do so, the total sum of
squares due to the variation of the overall mean (SST ) is calculated according to Equation
5.2:
SST =
n∑
i=1
(
S/Ni − S/N
)2
(5.2)
Where n is the total number of FE analyses, S/Ni is the S/N of the ith study and S/N is
the overall mean of S/N . Then, the sum of the squares due to the variation of the mean
was computed for each parameter (SSP ) as per Equation 5.3:
SSP =
m∑
j=1
(
S/NPj − S/N
)2
(5.3)
Where P refers to each design parameter, m is the number of discrete levels for each
parameter and S/NPj is the S/N at each level for each parameter. Finally, the
percentage contribution of each design parameter (ContributionP ) was determined
according to Equation 5.4:
ContributionP =
SSP
SST
(5.4)
5.2.3 Optimisation of Feasible Bone Cement Distribution
After studying the effect different bone cement distribution and associated parameters
had on the augmented femur yield load, it remained unclear which combination of values
would create the optimum augmentation strategy. For this reason, a further step was
taken to identify the optimum location and volume of bone cement for each one of the
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proposed distributions. The optimisation variables for each case are detailed below:
a. Spheres of bone cement
1. Three spheres located in a straight line: radius of each sphere (Ri for
i = 1, 2, 3) and centroid of spheres 1 and 3 (PXi, PYi, PZ)i for i = 1, 3).
Sphere 2 was located at the midpoint of the line joining these points.
2. Three spheres located in a curve: radius of each sphere (Ri for i = 1, 2, 3)
and centroid of each sphere (PXi, PYi, PZi for i = 1, 2, 3).
b. Channels filled with bone cement
1. One straight drilled channel: radius of the channel (R) and location of the
line start and end points (PXi, PYi, PZi for i = 1, 2).
2. Two straight drilled channels: radius of each channel (Rj for j = m,n)
and location of each line start and end points (PXij, PYij, PZij for i = 1, 2
and j = m,n).
3. One curved drilled channel: radius of the channel (R), length of the arc
(L) and location of the three points defining the circular curve (PXi, PYi, PZi
for i = 1, 2, 3).
4. Two curved drilled channels: radius of each channel (Rj for j = m,n),
length of each arc (Lj for j = m,n) and location of the three points defining
each circular curve (PXij, PYij, PZij for i = 1, 2, 3 and j = m,n).
The lower and upper bounds of the spheres and channel radius were retained from the
sensitivity analysis (Section 5.2.2): 5-9mm for the spheres and 3-5mm for the cylindrical
channels. The regions in which ideal distribution of bone cement was divided (Figure 5.1)
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were used to define the upper and lower bounds of the possible point locations, as well as
the maximum arc length.
The objective function (f) was the same for all modelled cases and aimed to minimise the
volume of bone cement (VPMMA) and maximise the augmented yield load (Y LAUG). The
only constraint applied to the optimisation was that the bone cement volume (VPMMA)
had to be smaller than 12ml. Both objective variables (VPMMA, Y LAUG) were normalised
as detailed in Equations 5.5, 5.6:
VPERC =
(
VPMMA
VMAX
)
· 100 (5.5)
Y LINC =
(
Y LAUG − Y LN/AUG
Y LN/AUG
)
· 100 (5.6)
Where VMAX (12ml) is the maximum volume of bone cement allowed for the optimisation
and Y LN/AUG (2625N) is the yield load of the non-augmented femur. The multiobjective
optimisation problem was solved using scalarisation, giving a larger weight to the yield
load increase function (Equation 5.7):
f = (0.2 · VPERC)− (0.8 · Y LINC) (5.7)
Optimisations were performed using patternseach in MatLab 2018 ( The MathWorks, Inc.,
Natick, Massachusetts, United States). The function evaluation to calculate the volume
of bone cement and percentage increase in the femur yield load was conducted using the
lateral fall boundary conditions described in Section 3.2.2 with ANSYS in batch mode.
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5.3 Results
Small differences were found in the augmented yield load when reinforcing the femur with
three spheres of bone cement in a straight-line or in a curve (Table 5.1). On average, a
4% difference was found between the two strategies, with placing spheres in a straight-line
outperforming placing them in a curve. In all cases, increasing the spheres radii resulted
in a higher volume of PMMA and hence, higher augmented yield load. The maximum
increase in the yield load was 54% when using 10ml of PMMA.
Table 5.1: Yield load increase (YLINC) after augmentation with spheres of bone cement
(VPMMA, volume of PMMA)
Spheres in Straight Line Spheres in Curve
YLINC VPMMA (ml) YLINC VPMMA (ml)
R=5mm 22% 1.6 20% 1.6
R=7mm 38% 4.7 35% 4.5
R=9mm 54% 10 46% 9.4
When placing bone cement in a single cylindrical channel, curved distributions displayed
higher improvements to the yield load (Table 5.2). As the channel radius increased, the
difference in augmented yield load between a single straight and curved channel became
higher, reaching up to 6%. When using two paths, curved channels performed better than
straight as the radius of the channel increased. The maximum obtained yield load increase
was 60% and 74% for one and two curved channels respectively. Using two channels
implied in all cases a significantly higher volume of bone cement than augmenting with
one channel, so it was expected to find a larger augmented yield load when compared
to the single channel equivalent. However, the ratio of yield load increase over PMMA
volume was always higher with one channel, suggesting a more efficient use of the bone
cement.
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Table 5.2: Yield load increase (YLINC) after augmentation with bone cement channels (VPMMA,
volume of PMMA)
One straight channel One curved channel
YLINC VPMMA (ml) YLINC VPMMA (ml)
R=3mm 28% 2.7 32% 3.0
R=4mm 42% 4.9 46% 5.4
R=5mm 54% 7.7 60% 8.1
Two straight channels Two curved channels
YLINC VPMMA (ml) YLINC VPMMA (ml)
R=3mm 40% 5.1 30% 4.5
R=4mm 56% 8.4 54% 7.8
R=5mm 72% 13.0 74% 11.5
When comparing all the different augmentation strategies (Figure 5.2), it can be seen that
for bone cement volumes of up to 8ml, the single curved channel strategy outperformed all
other approaches. However, since drilled paths with large radii can excessively damage the
cortical tissue, larger bone cement volumes required the use of two paths. In this case,
for bone cement volumes larger than 8ml, curved channels also performed better than
straight channels. Overall, the augmentation performance when reinforcing the femur
with three spheres of bone cement was lower than when filling a pre-drilled cylindrical
path with bone cement.
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Figure 5.2: Yield load increase vs bone cement volume for all studied bone cement
distributions.
After studying the aforementioned bone cement distributions, a sensitivity analysis was
performed in order to understand the effect of each parameter in the augmentation result.
The S/N response curves shown in Figure 5.3 depict the change in the result (augmented
yield load, as a S/N ratio) with variations in the three most significant design parameters.
In these plots, Level 2 represents the value from the original region centroids (Section
5.2.1) and Levels 1 and 3 represent the variations explained in Section 5.2.2. Taguchi
analyses showed that when spheres were placed in a straight or curved line, the three
factors that contributed the most to the increase of the femur yield load were the X, Y
coordinates of the first sphere centroid and the radius of the first sphere (PX1, PY1, R1).
As expected, increasing the radius of the first sphere resulted in a larger augmented yield
load. However, changing PX1, PY1 from their original level (Level 2) did not lead to any
improvements in the yield load.
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Figure 5.3: Taguchi S/N response curves for augmentation with three spheres of bone cement.
The three factors which displayed the highest contribution to changes in augmented femur
yield load when placing bone cement in three spheres are shown in Table 5.3. Similar
results were found when placing the spheres in a straight line and in a curve. For both
cases, parameters related to the first sphere were of greatest significance. The location
of the centroid of the first sphere showed the highest contribution to the augmentation
result (between 54% and 55%), while the radius of the first sphere was only responsible
for 12-13% of the changes.
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Table 5.3: Contribution of most relevant parameters in augmentation result with three spheres
of bone cement
Spheres in Straight Line Spheres in Curve
Parameter Contribution (%) Parameter Contribution (%)
PX1 39 PX1 42
PY1 16 R1 12
R1 13 PY1 12
For one channel of bone cement (straight or curved), Taguchi analyses concluded that
the three most relevant factors in the outcome of the simulation were the coordinates
X and Z of the fist point and the radius of the channel (PX1, PZ1, R). In both cases,
as shown in the S/N graph (Figure 5.4), increasing the radius of the channel or moving
the Z coordinate of the first point downwards may benefit the femoral strength after
augmentation.
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Figure 5.4: Taguchi S/N response curves for augmentation with one channel of bone cement.
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The significance of the three most relevant parameters in the augmented femur yield load
are shown in Table 5.4. In the straight single-channel distribution, the X coordinate of
the first point had the highest contribution to the final yield load (35%), followed by the
radius of the channel (12%) and the Z coordinate of the first point (9%). However, in the
single curved-channel case both the X and Z coordinate of the first point showed a similar
contribution to the femoral strength (30% and 28% respectively). These two factors
together with the channel radius accounted for 75% of the total contribution, indicating
that they may explain the majority of change to femur yield load after augmentation.
Table 5.4: Contribution of most relevant parameters in augmentation result with one channel
of bone cement
One straight channel One curved channel
Parameter Contribution (%) Parameter Contribution (%)
PX1 35 PX1 30
R 12 PZ1 28
PZ1 9 R 17
When augmenting with two channels of bone cement (straight or curved), Figure 5.5
shows the S/N ratios for the three most relevant factors. When the bone cement was
distributed as two straight channels, those factors were the X, Y and Z coordinates of
the first point of the first channel (PX1m, PY1m, PZ1m). For PY1m and PZ1m, increasing
or decreasing the original value (Level 2, from the region centroid) did not result in any
improvement, suggesting these are approaching optimum values. In the case of two curved
channels, the three most important parameters were the X coordinate of the first point of
the first and second channels and the Y coordinate of the third point of the second channel
(PX1m, PX1n, PY3n). In both straight and curved channels, moving the X coordinate
of the first point of the first channel (PX1m) away from the femoral head improved the
augmentation. Additionally, in both cases the location of the bone cement cylinder was
a more influential factor than the volume of bone cement (radius of each channel).
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Figure 5.5: Taguchi S/N response curves for augmentation with two channels of bone cement.
As shown in Table 5.5, the three most important factors when augmenting the femur with
two channels of bone cement were related to the position of such channels. These three
factors account for 56% and 48% of the total contribution for two straight and two curved
channels respectively. Furthermore, contribution of the channels’ radii in the case of two
straight channels is of greater significance (10% first channel, 8% second channel) than in
the case of two curved channels (3% first channel, 4% second channel).
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Table 5.5: Contribution of most relevant parameters in augmentation result with one channel
of bone cement
Two Straight Channels Two Curved Channels
Parameter Contribution (%) Parameter Contribution (%)
PX1m 28 PX1m 21
PY1m 17 PY3n 18
PZ1m 11 PY1n 9
The goals of the feasible bone cement distribution optimisation were to maximise yield
load and minimise bone cement volume of the augmented femur. A comparison of these
two parameters between optimised and non-optimised distributions when using three
spheres of bone cement is presented in Figure 5.6. Results show that for both
augmentation strategies (spheres in a straight line and in a curve), the optimisation
achieved an increase in augmented yield load and a decrease in bone cement volume.
Additionally, both strategies performed similarly, obtaining an average increase of 71%
in the femur yield load with 8.6ml of bone cement.
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Figure 5.6: Yield load increase and bone cement volume for optimised and non-optimised
augmentation with three spheres of bone cement.
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The placement and radius of the spheres before and after optimisation is shown in Figure
5.7. The optimised distributions were similar for both strategies and consisted of placing
bone cement in the superior aspect of the femoral neck, as close as possible to the cortical
bone.
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Figure 5.7: Bone cement distribution for optimised and non-optimised augmentation with
three spheres of bone cement.
When augmenting the femur with bone cement channels, results show that the yield load
increase was always higher in the optimised results compared to the non-optimised ones
(Figure 5.8), with a maximum difference of 20%. Similarly, the optimisation reduced the
required bone cement volume, especially in the cases involving two channels. Additionally,
augmentation with two channels performed marginally better than augmentation with one
channel (7% difference on average).
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Figure 5.8: Yield load increase and bone cement volume for optimised and non-optimised
augmentation with channels of bone cement.
With respect to the distribution of the bone cement inside the femur, Figure 5.9 shows the
changes between non-optimised and optimised results. The non-optimised distributions
for one straight and one curved channel were similar, although the curved channel was
slightly more proximal. For the same cases, in the optimised distribution, the medial
end of the bone cement channel was moved upwards. In the case of two straight and
curved channels, there are significant differences between the optimised and non-optimised
distributions. In the non-optimised distributions, one channel went from the greater
trochanter to the superior part of the femoral neck and the other went from the greater
trochanter to the inferior part of the femoral neck. However, in the optimised distribution,
the main channel was placed from the greater trochanter to the superior part of the femoral
neck and the other channel was located as reinforcement in the greater trochanter area.
None of the optimised cases involved the reinforcement of the inferior part of the femoral
neck.
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Figure 5.9: Bone cement distribution for optimised and non-optimised augmentation with
channels of bone cement.
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5.4 Discussion
Different femoral augmentation strategies have been proposed and studied in the past
years. The most common ones consist of injecting small amounts of bone cement in
specific locations (Basafa et al., 2015; Farvardin et al., 2019) and drilling one or several
paths in the bone and filling them with bone cement (Beckmann et al., 2011; Fliri et al.,
2013; Raas et al., 2016; Varga et al., 2017). In the present chapter, both approaches with
some feasible variations were studied and optimised for a specific case of a femur with
T-Score -2.5 under lateral fall boundary conditions.
Only small differences were found when augmenting the proximal femur with three spheres
in a straight line or in a curve; the distributions of bone cement, Taguchi analyses and
optimisation results were similar in both cases. In both cases, the Taguchi analyses
identified the X coordinate, Y coordinate and radius of the first sphere as the main
contributing factors to the augmentation result. Additionally, it was found that when
these centroid points were moved away from their original location, the augmented yield
load decreased. This was also true for the centroids of the other spheres except the X and
Z coordinate of the third sphere, suggesting that the original distribution presented in
Section 5.2.1 was close to an optimum solution. The patternsearch optimisation confirmed
this, since in the optimised distributions the centroid of the first two spheres did not move
significantly from their original location.
Optimisation results when augmenting the proximal femur with three bone cement
spheres denoted the importance of reinforcing the greater trochanter and the superior
aspect of the femoral neck. This optimised distribution is consistent with results found
with the Evolutionary Structural Optimisation (ESO) algorithm presented by Basafa
and Armand (2013). In these studies, the evolution of cement placement with the ESO
algorithm showed that the first region to augment was the greater trochanter, followed
by the femoral neck. In the present study, the optimised distribution resulted in an
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average yield load increase of 71% (VPMMA=8.6ml), while non-optimised cases led to a
maximum 54% increase in the yield load (VPMMA=10ml). A similar type of distribution
and range of bone cement volumes were studied experimentally by Basafa et al. (2015)
(average yield load increase 31.3% with 9.5ml of PMMA) and numerically by Farvardin
et al. (2019) (average yield load increase 79.6% with 10ml of PMMA).
Taguchi analyses conducted for one channel of bone cement showed that channel radius
was an important augmentation factor, contributing up to 17% to the result. This was
expected since increasing the channel radius also increased the bone cement volume.
However, the contribution of the X and Z coordinates of the first point of the channel
were more significant and added to 44% and 58% for the straight and curved channel
respectively. These results suggest that in such cases, bone cement placement played a
more important role in femoral augmentation than the amount of bone cement. Similarly,
results of Taguchi analyses for two bone cement channels (straight and curved) showed
that path placement had a more important effect than path diameter on the augmentation
result.
In the cases of augmentation with a single channel of bone cement (straight or curved),
optimised results performed better than non-optimised results both in terms of yield load
increase and bone cement volume. In these cases, optimised distribution for straight and
curved channels was of similar topology and provided a similar augmentation level. This
distribution consisted of placing bone cement in a channel in the superior region of the
proximal femur that went from the greater trochanter to the femoral neck. Given that
most proximal femur fractures due to a lateral fall initiate at the superior aspect of the
femoral neck (de Bakker et al., 2009; Nawathe et al., 2014), reinforcing this region might
help avoid the fracture. Moreover, results from this optimisation align well with the
ones presented by Varga et al. (2017), who decided on the bone cement location through
numerical analyses based on Wolff’s law. Their results suggest that placing bone cement
from the femoral head to the greater trochanter and ensuring cement contact with the
superior cortex of the femoral neck provided better augmentation results than placing
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bone cement aligned with the femoral neck axis. However, results in this chapter show
that the optimum solution does not involve extending bone cement through the femoral
head as presented by Varga et al. (2017).
When augmenting the osteoporotic femur using two drilled channels, the distribution of
bone cement in the optimised and non-optimised cases are significantly different. The non-
optimised distribution consisted of a V-Shape augmentation with the entry point in the
greater trochanter area and provided a significant increase (50%) in the femur yield load.
This augmentation strategy had already been studied by Raas et al. (2016); Fliri et al.
(2013), who did not report significant improvements in the femur yield load. However,
the entry point for their augmentation was located in the lateral cortex of the proximal
femur, at the extension of the central neck axis. Beckmann et al. (2011) also performed
a V-shaped augmentation but using two insertion holes. Their results showed that this
strategy weakened the bone, possibly due to the damage to the cortical bone. In the
present study, optimisation results for this case consisted of one channel in the superior
part of the femoral neck and a second, smaller channel to reinforce the greater trochanter
region. The optimised distributions showed higher yield loads than the non-optimised,
suggesting that placing bone cement in the inferior part of the femoral neck may not be
necessary.
Due to the large number of factors than can influence bone cement distribution for all
the proposed approaches, the Taguchi analyses were limited to three levels of design
parameters. However, even with this limitation the Taguchi analysis combined with an
ANOVA test were a powerful tool to assess relative importance of bone cement volume
and location factors in different augmentation strategies. The main conclusion from the
Taguchi analyses was that, within the studied variables range, the bone cement location
was more important than the bone cement volume in the augmentation result.
In all studied cases, the optimised feasible bone cement distributions provided better
results than non-optimised distributions in terms of femur yield load increase and bone
cement volume. Therefore, despite the original distributions derived from the centroids
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of the ideal bone cement cloud resulted in significant improvements to femur yield load
(up to 74% with 11.5ml of PMMA), results could still be improved. Additionally, starting
from the ideal bone cement cloud was an important step as it decreased the size of
some design variables and the computational time of the patternsearch optimiser. The
maximum channel or sphere radii were design variables that also had to be limited to
avoid potential bone damage when drilling the femur in practice. In the optimisation,
the scalarisation method was used to convert a multi-objective function (minimise bone
cement volume and maximise yield load) into a single function. To do so, different weights
were given to the bone cement volume function and to the yield load function and this
determined the performance priority and therefore the solution (Gunantara, 2018). Other
approaches, such as the Pareto method or different weight distributions might affect the
optimisation result and could be explored in the future.
When comparing all the optimised augmentation strategies (Figure 5.10) it is clear that
performance using curved and straight paths is similar. Therefore, despite the slightly
better performance of curved bone cement distributions, this is not enough to justify the
additional work required to achieve this augmentation in practice. Additionally, given the
similarities in bone cement distribution, the performance of augmentation with one or two
channels was similar. After the optimisation, the yield load increase when injecting bone
cement in the form of spheres or cylinders was also alike. Hence, given the similarity in the
results, the choice between methods depends on which one is easiest to replicate in practice
and would entail less practical and clinical risks. The main drawbacks of injecting spheres
are the need for three injection points and a navigation system to control the location of
each injection. Alternately, although injecting bone cement in a single path is easier to
achieve in practice, the risk of bone thermal necrosis is potentially higher. While injecting
three spheres of bone cement is a procedure that can be done in separate stages (waiting
until polymerisation of a sphere finishes before starting the new injection), in the case of
a cylinder all the bone cement should be injected at once.
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distributions.
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Augmented and Non-Augmented
Femur Fracture Prediction
6.1 Introduction
Several generalised augmentation strategies were proposed in Chapter 5 and tested in
one femur with a specific level of osteoporosis (T-Score -2.5), with results suggesting
that a significant increase in yield load could be achieved. However, experimental
studies (Beckmann et al., 2011; Springorum et al., 2014; Basafa et al., 2015) have proven
that the efficacy of femoral augmentation is highly dependent not only on the type,
volume and location of bone cement but also on the original bone material properties.
Additionally, given that osteoporosis will continue developing with time, it is of interest
to understand how the result of the same augmentation strategy will change while the
bone material properties degrade. Hence, in this chapter the increase of fracture load
and energy to fracture was monitored in femora with different levels of osteoporosis after
being augmented using the generalised strategies presented in Chapter 5.
The increase in fracture and/or yield load are the most commonly used parameters to
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measure the effectiveness of femoral augmentation. However, it is also important to
understand how introducing bone cement into an osteoporotic bone can affect its
behaviour in case of a fracture. With this, it would be possible to determine if the
augmented femur would present a worse fracture (in terms of ease of fixation and
potential complications) than the non-augmented femur. Examining and comparing
fracture location and patterns of augmented and non-augmented femora could provide
this information. Using numerical approaches, few studies have developed a
methodology to predict femur fracture load and crack propagation. Some employed the
eXtended Finite Element Method (XFEM) and obtained small fracture paths (Marco
et al., 2017; Ali et al., 2014), while others considered that modelling the degradation of
material properties through a damage variable could be used to simulate bone fracture
(Hambli et al., 2012; Hambli and Allaoui, 2013). Element deletion has also been
investigated. (Marco et al., 2018), but presents more convergence problems than other
approaches. Recently, Marco et al. (2018) compared different strategies and concluded
that the degradation of bone mechanical properties approach presented the best results
and performance.
The first objective of this chapter was to determine the increase in fracture load and
energy to fracture of femora with different osteoporotic levels augmented with the
generalised approaches presented in Chapter 5. The second objective was to study
whether augmentation with bone cement changed the fracture pattern in the
aforementioned cases, resulting in more complicated fractures. Finally, the third
objective was to determine if small modifications applied to a single-cylinder
augmentation strategy could improve the augmented fracture load.
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6.2 Methods
6.2.1 Prediction of Femoral Fracture Load and Crack
Propagation
All the femur FE (Finite Element) models developed in Section 3.2.1, with T-Score ranging
from -1.0 to -3.5 were used within the computational studies of this chapter. Each femur
mesh was imported to ANSYS Mechanical APDL to perform the Finite Element Analyses
(FEA). The augmented tissue was modelled as a composite made of bone and porous bone
cement. Material properties were computed by applying the Voigt-Reuss-Hill average
and including bone cement porosity, as described in Section 4.2.1. For each femur, three
different cases or augmentation strategies (specific volume of bone cement in a predefined
location) were studied (Figure 6.1):
V0. Non-augmented femur.
V1. Femur augmented with one cylinder of bone cement. This distribution was the
result of the single-path optimisation presented in Section 5.2.3. Bone cement was
distributed in a cylinder aligned with the superior part of the femoral neck, starting
at the greater trochanter and extending for a length of 7cm. Total volume of bone
cement for this augmentation was 6.7ml.
V2. Femur augmented with two cylinders of bone cement. This distribution was the
result of the two-path optimisation presented in Section 5.2.3. The first cylinder
was aligned with the superior part of the femoral neck, starting at the greater
trochanter and extending for a length of 6.5cm and the second cylinder was smaller
and only reinforced the trochanter region. Total volume of bone cement for this
augmentation was 7.5ml.
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V2 (2 PMMA Cylinders)V1 (1 PMMA Cylinder)V0 (Not Augmented)
Figure 6.1: Non-augmented (V0) and augmented (V1, V2) cases studied in fracture analysis.
Boundary conditions replicating a lateral fall onto the greater trochanter were applied to
each model (Figure 6.2). Surface nodes in the femoral head were coupled with constraint
equations to node A, where a displacement was incrementally applied. The displacement
was applied in X, Y and Z directions, corresponding to a rotation of the femur of 10° in
the transverse plane and 15° in the frontal plane. Surface nodes in the greater trochanter
were coupled with constraint equations to node B. In node B, displacement in X and Y
directions was set to zero, while displacement in Z direction was unconstrained. Node C
was then added to the mesh and attached with rigid beam elements to the distal end of the
femur. In this node, all the displacements were constrained except the rotation around
the Y axis. This set of boundary conditions is commonly used to replicate a lateral
fall onto the greater trochanter in experimental studies (Dragomir-Daescu et al., 2011;
Zani et al., 2015; Altai et al., 2019). Therefore, they have been changed from previous
chapters to allow comparison between the load-displacement curves, fracture load and
fracture patterns found in this chapter and experimental ones.
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Figure 6.2: Lateral fall boundary conditions applied in fracture analysis.
In order to simulate crack propagation in the femur, a nonlocal damage model based
on Continuum Damage Mechanics was included in the simulations (Hambli et al., 2012).
An isotropic damage variable (D) was included to represent degradation of the elastic
modulus during the loading process:
E˜ = (1−D)E (6.1)
Where E˜ is the elastic modulus of the damaged material and E is the original elastic
modulus of the material. The damage variable (D) was calculated using a damage law
based on the averaged maximum principal strain of each element (ε¯max) at every step of
the loading process:
D = 0 ; ε¯max ≤ ε0 (6.2)
D =
(
ε¯max
εf
)n
; ε¯max < ε0 < εf (6.3)
D = 1 ; ε¯max ≥ εf (6.4)
Where:
D = damage of each element
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ε¯max = averaged maximum principal strain of each element
Non-local averaging (Equation 6.5) was applied in order to prevent localization and ensure
predictions were independent of mesh size. The maximum principal strain of each element
was averaged over a neighbourhood of the element (elements located within a 1.5mm
radius sphere):
ε¯(x) =
∑n
i=1 εi
n
(6.5)
ε0 = damage strain threshold representing damage start: 0.1% for both bone and bone
cement (Wolfram et al., 2011).
εf = strain at fracture: 2.605% in tension and 2.1% in compression for the bone (Reilly
et al., 1974) and 2.6% for the bone cement (Spierings, 2005).
n = damage exponent: 1.5 (Wolfram et al., 2011).
The crack propagation simulation was performed in ANSYS following an iterative
procedure. Initially, a small displacement was applied to node A and using the
previously described lateral fall boundary conditions, the FEA was solved. The averaged
maximum principal strain (absolute value) and damage variable were computed for each
element and the reaction force was calculated in node A. For each element:
• If D = 0, nothing was changed from the element.
• If 0 < D < 1, the elastic modulus of the element was reduced by the value 1−D.
• If D = 1, the element was killed and its mechanical contribution to the stiffness
matrix was set to zero.
When the model stiffness was updated, the displacement was increased, and the procedure
was repeated until the reaction force in node A was smaller than 500N.
Additionally, this simulation was performed with three different meshes of a representative
91
CHAPTER 6
femur (T-Score -2.5) (Figure 6.3) in order to verify the mesh independence of the damage
law.
Extra Coarse Coarse Normal Fine
Figure 6.3: Meshes used in the mesh independency analysis for fracture prediction.
6.2.2 Patient-specific Bone Cement Distribution Based on
Fracture Prediction
In order to find a patient-specific bone cement distribution for femur augmentation, an
algorithm based on the ESO technique was developed. This method used the single-
cylinder bone cement distribution (V1) as the initial point for the simulation and, if
needed, added bone cement in the regions surrounding the cylinder. The procedure is
detailed below:
Define the region of elements that can be augmented: those surrounding the initial bone
cement region
Apply initial displacement and boundary conditions replicating a sideways fall
While the total PMMA volume is < 12ml:
Run FEA
Apply damage law and find elements that fail
Select failed elements inside the region that can be augmented
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Change material properties of those elements to bone cement
Select failed elements outside the region that can be augmented
Kill those elements
Increase the applied displacement and repeat
6.3 Results
Results of the mesh independence analysis performed for a representative femur using
three different mesh sizes is shown in Figure 6.4. For each model, fine mesh results
were used as reference to compare results generated with other meshes. The percentage
difference in ultimate load between meshes remained less than 5% in all cases (4.95%
and 2.01% for coarse and normal meshes respectively). Additionally, the shape of the
predicted load-displacement curve was similar for all mesh sizes.
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Figure 6.4: Predicted load-displacement curves for three different mesh sizes.
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Figure 6.5 shows load-displacement curves for an osteoporotic femur with T-score -2.5
in its non-augmented state (V0) and after being augmented with one (V1) or two (V2)
cylinders of bone cement. In all cases, the curves show initial linear behaviour followed by
a nonlinear phase, when damage starts and grows. After this, there is a sharp decrease to
the load indicating a fracture. The ultimate load of the non-augmented femur was 2778N,
which increased by 62% when augmenting with one cylinder of bone cement and by 66%
with two cylinders of bone cement.
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Figure 6.5: Load-displacement curve for augmented and non-augmented femur (T-Score -2.5).
The predicted fracture patterns for the femur with T-Score -2.5 are depicted in Figure
6.6. For the three studied cases, the main crack leading to fracture started in the superior
part of the femoral neck, near the greater trochanter. However, the crack propagated
differently depending on volume and location of bone cement. In the non-augmented case
(V0), a single crack was developed that grew across the femoral neck. In the V1 case (one
cylinder of bone cement) the main crack bifurcated, and a second, smaller non-fracture
forming crack developed closer to the femoral head. When augmenting with two cylinders
of bone cement (V2) the main crack bifurcated, moving the fracture slightly closer to the
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femoral neck.
V2 (2 PMMA Cylinders)V1 (1 PMMA Cylinder)V0 (Not Augmented)
Figure 6.6: Femur fracture patterns in augmented and non-augmented femur model (T-Score
-2.5).
Cracks leading to fracture can also be observed in a cross-sectional view of the femur.
Final damage distributions of each simulation for three different augmented and non-
augmented femora are shown in Figure 6.7, where D = 1 represents the failed elements.
The main fracture pattern did not change significantly with the degree of osteoporosis or
augmentation strategy. In all non-augmented cases (V0) there is a single path that leads to
fracture, while in augmented cases (V1, V2) several cracks appeared in the superior cortex
of the femoral neck. Despite these smaller cracks propagating less than the primary crack,
they could contribute to create a comminuted fracture (fracture with multiple pieces and
fracture lines). Furthermore, it can be observed that the differences between augmented
and non-augmented fractures increase as the degree of osteoporosis increases.
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Figure 6.7: Damage at last step of simulation for different augmented and non-augmented
femur models.
The fracture load and energy to fracture for all studied osteoporotic levels and
augmentation cases are summarised in Table 6.1. For all T-Score levels, using one or two
cylinders of bone cement led to a similar increase of the studied biomechanical
properties. On average, when using the generalised augmentation strategies, fracture
load and energy to fracture were increased by 52% and 81% respectively in osteopenic
models (T-Score from -1.0 to -2.0) and by 72% and 126% in osteoporotic models
(T-Score from -2.5 to -3.5).
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Table 6.1: Fracture load and energy to fracture for all augmented and non-augmented femur
models.
Fracture Load (N) Energy to Fracture (J)
T-Score V0 V1 V2 V0 V1 V2
-1.0 4330 6282 6397 9.29 15.56 15.54
-1.5 3752 5618 5789 7.87 14.50 14.62
-2.0 3257 4966 5219 6.74 12.62 13.05
-2.5 2778 4503 4614 5.75 12.47 11.75
-3.0 2283 3863 3929 4.65 10.53 10.11
-3.5 1864 3367 3393 3.70 9.23 8.99
In all studied cases, the relative increase in fracture load and energy to fracture decreased
as non-augmented femoral strength increased (Figure 6.8). Hence, when using a constant
volume of bone cement weaker bones obtained greater benefits after augmentation.
The relative increase in biomechanical properties when using the patient-specific
distribution is shown in Figure 6.9. Results of generalised augmentations are also shown
in the figure for comparison. Patient-specific augmentation performed significantly
better than generalised distributions, but also required more bone cement
(approximately 12ml). On average, when using patient-specific augmentation strategies,
fracture load and energy to fracture were increased by 77% and 152% respectively in
osteopenic models and by 93% and 203% in osteoporotic models.
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Figure 6.8: Relative changes in fracture load and energy to fracture for augmentation strategies
V1 and V2.
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Figure 6.9: Relative changes in fracture load and energy to fracture for patient-specific
augmentation.
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Patient-specific bone cement distribution in the femur (for a T-Score of -2.5) is shown in
Figure 6.10. The primary regions where bone cement was added were the medial part of
the original cylinder and the superior aspect of the femoral neck. Similar distributions
were created for all models with different T-Score levels.
Figure 6.10: Patient-specific bone cement distribution for femur with T-Score -2.5.
6.4 Discussion
Mesh sensitivity is a common challenge when using FE methods to simulate damage
and softening behaviour. When using local damage models, crack path and damage
patterns are highly influenced by mesh orientation and size. In this case, as the mesh
is refined, the failed region and energy dissipation shrink to unrealistic values. To avoid
this issue, some proposed models include mesh regularization, consisting of adjusting the
failure strain of each element based on its size (Hambli and Allaoui, 2013) or gradient-
based nonlocal methods (Haider et al., 2018). In the present study, a nonlocal damage
model was presented, where damage evolution was driven by an averaging of strains
near a point. A similar technique, using weighted spatial averaging has been successfully
applied in failure simulations of vertebral bone (Charlebois et al., 2010) and acrylic bone
cement (Stolk et al., 2003). The method proposed in this chapter was implemented in a
commercial FE package and tested through a mesh dependency analysis. Results showed
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that the load-displacement curve and fracture pattern were not heavily influenced by mesh
size, suggesting this technique can overcome mesh sensitivity issues.
In order to simulate bone fracture, a criterion based on the maximum principal strains
in both tension and compression was incorporated in the damage model. Given the
evidence suggesting that yield and fracture strain of bone tissue do not depend on bone
density (Bayraktar et al., 2004; Morgan et al., 2004), fracture strain values were defined as
constants (Reilly et al., 1974). However, some fracture models in the literature incorporate
relationships between bone density and strain limit (Hambli and Allaoui, 2013; Dragomir-
Daescu et al., 2011).
The predicted non-augmented femur fracture load ranged from 1864N to 4330N for a
sideways fall configuration in femora with T-Score ranging from -1.0 to -3.5. On average,
the femur fracture load for each T-Score was found to be 6% higher than the yield load
calculated in Chapter 3. Failure loads for osteopenic and osteoporotic femora reported
in this chapter were similar to the ones obtained in previous experimental studies that
applied comparable loading conditions. For osteopenic femora, de Bakker et al. (2009)
found an average fracture load of 3600N (average T-Score -1.74), similar to the fracture
load of 3752N found in this chapter for the femur with T-Score -1.5. For osteoporotic
femora, Schileo et al. (2014) found an average fracture load of 2516N (mean T-Score
-2.97) and Pottecher et al. (2016) reported an average ultimate load of 2480N (mean
T-Score -2.59). These are similar to the fracture loads of the femora with T-Score -2.5
and -3.0 presented in this chapter (2778N and 2283N respectively). Higher fracture loads
have been found by Dragomir-Daescu et al. (2011) (average load of 4116N and 2362N for
femora with average T-Score -1.78 and -3.47 respectively). Differences may be due to the
femur lengths, differences in geometry and type of osteoporosis and/or load displacement
rate (100mm/s for Dragomir-Daescu et al. (2011) and de Bakker et al. (2009); 17.5 to
32.5mm/s for Schileo et al. (2014)).
The fracture prediction study was also performed with augmented femora in order to
identify the changes in fracture load and crack propagation. On average, augmenting
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the femur with 7ml of bone cement in one cylinder (V1) increased the fracture load
by 60% and the energy to fracture by 105%. These results can be compared to the
experimental results of Beckmann et al. (2011); Springorum et al. (2014), who also injected
bone cement in a single channel. Beckmann et al. (2011) performed a single centrodorsal
augmentation using 12ml of bone cement and obtained a 35% and 164% increase in
fracture load and energy to fracture respectively. Springorum et al. (2014) found similar
results (33% increase in fracture load and 117% increase in energy until fracture), injecting
less than 15ml of bone cement in a dorsocaudal drilling. In a computational study, Varga
et al. (2017) also placed bone cement in cylindrical distributions and reported a 59%
increase in fracture load with 12ml of bone cement. However, in their study bone cement
extended through the femoral head, which may contribute to the difference in bone cement
between this and the present study.
Results of this study also show that distributing 7ml of bone cement in two cylinders (V2),
resulted in an average increase of 64% in fracture load and of 102% in energy to fracture.
Femoral augmentation with two channels of bone cement (V-Shaped augmentation) has
been experimentally performed in the literature by Fliri et al. (2013); Raas et al. (2016),
resulting in increased energy to fracture but no changes in fracture load. However, in a V-
Shaped augmentation the bone cement channel diverges from below the greater trochanter
to the superior and inferior part of the femoral neck, while the two-channel distribution of
this study consisted of one channel from the greater trochanter to the femoral neck and a
small, second channel reinforcing the greater trochanter region. The superior performance
of the augmentation strategies presented in this study, both in terms of bone cement
volume and increase of strength, highlights the importance of bone cement placement
in femoral augmentation. Furthermore, in agreement with previous computational and
experimental studies (Springorum et al., 2014; Basafa et al., 2015; Varga et al., 2017),
results presented in this chapter suggest that the effect of reinforcement is also related to
original bone material properties (Figure 6.11). Therefore, using the same bone cement
volume, weaker femora experienced a larger relative increase of biomechanical properties
than stronger femora.
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Figure 6.11: Relative increase in fracture load in previous femoral augmentation studies and
present study.
Crack propagation leading to fracture in augmented and non-augmented femora was also
studied in this chapter. According to (Cauley et al., 2009), fractures of the femoral neck
and the intertrochanteric region account for over 90% of hip fractures and occur in nearly
equal proportions. The type of fracture generally depends on multiple factors such as Bone
Mineral Density (BMD), fall characteristics, sex, age and functional difficulties (Fox et al.,
2000). In this study, femoral neck fractures were predicted for the six non-augmented
femora. In all cases, fractures started with damage accumulation at the superior aspect
of the femoral neck, and this damage increased and propagated through the neck. This
is in agreement with the findings of de Bakker et al. (2009), who used loading conditions
similar to the ones of this chapter and reported that femoral neck fractures initiate in the
superior cortex of the neck due to high compressive strains and are followed by failure
in the inferior aspect of the neck. Moreover, as can be seen in Figure 6.12 the fracture
patterns obtained in this study are similar to fractures seen in experiments that apply
lateral fall loading conditions (de Bakker et al., 2009; Dragomir-Daescu et al., 2011; Schileo
103
CHAPTER 6
et al., 2014). Fracture paths of male, osteoporotic femora are shown, since the femur model
of the present study is only valid for femora with senile osteoporosis (common in men).
Present study              de Bakker et al. (2009)      Dragomir-Daescu et al. (2011)           Schileo et al. (2014)
Figure 6.12: Fracture patterns obtained in previous experimental studies and in the present
chapter.
Augmentation with approximately 7ml of bone cement increased fracture load but did
not lead to significant changes in the main fracture path. This is consistent with
previous experiments in the literature using less than 18ml of bone cement (Beckmann
et al., 2011; Springorum et al., 2014) that reported no significant changes in fracture
pattern or location after augmentation. Other experiments suggest that when using
larger amounts of bone cement, fracture location changes significantly (Heini et al.,
2004). Despite the main fracture location remaining unaltered, the present study shows
that after augmentation, some smaller cracks were generated in different locations along
the femoral neck. This suggests that fracture of an augmented femur could lead to a
comminuted fracture and present complications in the fixation procedure. This
phenomenon was also observed in the experiments performed by Beckmann et al.
(2011), who reported an increase of multifragmentary fractures in the cemented femora.
Additionally, as osteoporosis increased the changes between augmented and
non-augmented fracture pattern also increased.
After studying the load-displacement curve and fracture pattern of bones augmented
using two generalised strategies (V1, V2), a patient-specific distribution was found using
an ESO algorithm. This distribution could be achieved in practice with two channels of
bone cement diverging from the greater trochanter to the posterior and anterior region
of the femoral head. Since osteoporosis was virtually introduced in the FE models (as
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explained in Section 3.2.1), patient-specific bone cement distributions were similar for
all T-Scores and patient-specific results are only applicable to the studied femur. Such
configurations suggested that more reinforcement was needed in the superior aspect of
the femoral neck, given it is the main region where fractures started. This bone cement
distribution led to a higher increase of biomechanical properties than the two original
distributions (average 85% increase in fracture load and 178% in energy to fracture).
However, it also required a larger amount of bone cement (12ml) and was patient specific.
The required increase in fracture load and energy to fracture in order to prevent an
osteoporotic hip fracture in the event of a fall remains unclear (Fliri et al., 2013). Hence,
it is difficult to decide whether the more complex injection pattern and increased bone
cement volume in the patient-specific augmentation is justifiable.
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2D Modelling of Bone Cement
Injection and Curing in Osteoporotic
Femur
7.1 Introduction
Results obtained in previous chapters show that a predefined PMMA bone cement
volume placed in a specific location can significantly improve the mechanical strength of
osteoporotic femora. However, injecting bone cement into an osteoporotic bone presents
certain risks that need to be investigated. Some potential complications of femoral
augmentation are linked to bone cement leakage and increase of intraosseous pressure
during the injection process (Xie et al., 2016). A further risk is thermal necrosis of
tissues near the bone cement associated with the PMMA exothermic polymerisation
process (Zeiser et al., 2008; Pearce et al., 2005). Additionally, shrinkage of bone cement
during its solidification can lead to debonding or regions of high stress (Kwong and
Power, 2006). Computational models could be able to predict some of the risks and
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provide alternatives to minimise them. As an additional benefit, they could be used as a
tool to support clinicians plan patient-specific interventions. Therefore, a first step is to
study the flow behaviour of bone cement when injected into the trabecular bone. This
will provide information about the bone cement distribution during injection and the
possibility of developing non-filled cavities in the bone depending on factors like bone
cement viscosity or bone cement porosity. Then, simulating the bone cement
solidification process is necessary to evaluate the risk of thermal necrosis and regions of
stress concentration.
Previous numerical work studying flow behaviour of bone cement in the femur focused
on microscale models of trabecular bone specimens. In this field, Basafa et al. (2013)
applied Smoothed Particle Hydrodynamics and created an experimentally validated
model to study bone cement injection in small cubes of surrogate porous bone models.
Similarly, Nawathe et al. (2014) investigated the flow of PMMA bone cement with
different viscosities in small cubes with trabecular morphology using a Discrete Particle
Model. Despite the limited extent of literature regarding the injection process in femoral
augmentation, this matter has been examined using diverse computational approaches
for vertebral augmentation. Meng (2008) employed Computational Fluid Dynamics
(CFD) analysis to simulate PMMA flow into a macroscopic model of a vertebral body
while applying Darcy’s law. Given that this model omitted the trabecular
microstructure of the bone, permeability values were extracted based on the Hounsfield
Unit (HU) of the vertebral CT scan. Using the Theory of Porous Media (TPM), Bleiler
et al. (2015) modelled simultaneously PMMA fluid flow and mechanical loading of the
bone structure. Less common approaches such as lattice Boltzmann simulations (Zeiser
et al., 2008) or time-lapse CT (Stadelmann et al., 2016) have also been used to
investigate bone cement injection in vertebral bodies. However, one important difference
between vertebral and femoral augmentation is the injection procedure. While in
vertebral augmentation the cannula used to inject the bone cement does not move, in
femoral augmentation the cannula is initially inside the bone and is retracted while
injecting. Given this is an issue related to femoral augmentation that should be studied
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with a macroscopic model, none of the aforementioned studies have adequately
investigated bone cement flow under femoral augmentation conditions.
Developing a model of bone cement flow in femoral augmentation is a first step that
should be followed by the simulation of the PMMA polymerisation process inside the
bone. Generally, this process involves an exothermic reaction from the curing process
and both chemical and thermal deformation in the bone cement. Some authors have
focused on the temperature distribution in the bone cement during the curing process.
For instance, Hansen (2003), who developed a heat transfer model based on the
principles of polymerisation kinetics and Farvardin et al. (2018), who studied
temperatures developed in a 3D model of augmented femur using data from
experimental measurements. Stanczyk and Rietbergen (2004) also studied the
temperature distribution at the bone-PMMA interface using a microstructural model of
bovine trabecular bone. Other authors have proposed methods to simulate both heat
transfer and PMMA deformation related to the polymerisation process. In this field,
Pe´rez et al. (2009) evaluated temperature distribution and residual stresses after
polymerisation for an idealised femoral stem, using a coefficient of thermal expansion
dependant on the PMMA elastic modulus to model deformation. A similar approach
was presented by Briscoe and New (2010), but shrinkage was modelled proportional to
the degree of polymerisation. However, in both studies only a thin layer of bone cement
was analysed in the context of prosthesis fixation, which differs from bone cement
distributions required in femoroplasty. Using a trabecular microstructural model,
Landgraf et al. (2015) simulated bone cement injection and solidification. Both chemical
and thermal shrinkage were modelled, although the methodology was not applied to a
full-scale model of the bone. None of the aforementioned macroscopic studies analyse
the debonding that might occur between the bone and the PMMA. In this field, Hung
and Chang (2010) modelled the debonding behaviour at the interface of these two
materials measuring tensile and shear strength and validated their results
experimentally. Similarly, Pe´rez and Palacios (2010) developed a more complex FE
model to simulate the debonding process considering damage accumulation due to
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normal and shear stresses.
The first objective in this chapter is to develop a 2D CFD model that can simulate bone
cement injection in the framework of femoral augmentation and be applied to a
macroscale femur model. Different injection velocities were studied and PMMA
distribution and intraosseous pressure were monitored. After studying bone cement
flow, the second objective was to simulate bone cement polymerisation inside the femur
considering heat transfer as well as chemical and thermal expansion/shrinkage. Shear
stresses at the PMMA-bone interface were examined and used to evaluate potential
debonding regions.
7.2 Methods
7.2.1 Simulation of Bone Cement Injection
The simulation of bone cement injection was performed in a 2D femur model created
using the CT scan and methodology described in Chapter 3. In order to replicate the
femoral augmentation procedure, a cannula was included in the model as depicted in
Figure 7.1. The diameter and length of the path drilled in the femur were 7mm and
67mm respectively. A triangular, unstructured mesh of the 2D femur and cannula was
created, including boundary layers in the cannula walls.
Trabecular bone in the proximal femur is formed of bone tissue and bone marrow.
However, given the complex structure of the trabecular bone tissue, simulating the flow
of cement in a femur using micro-scale detailed geometry would result in a complex and
computationally intensive model. For this reason, bone tissue was represented as a
porous continuum medium filled with bone marrow. Bone marrow in the trabecular
tissue was defined as a Newtonian fluid with constant viscosity (material properties
according to Landgraf et al. (2015)). The fluid flow through a porous media is described
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Figure 7.1: 2D femur and cannula model.
by the Darcy equation (Equation 7.1):
q = −kA
η
dp
dL
(7.1)
where k is the permeability, representing the ability of the medium to transmit fluids;
q is the volumetric flow; dp/dL is the pressure drop per unit length; η is the kinematic
viscosity of the fluid; and A is the cross-sectional area.
The permeability of bone tissue depends on the morphological properties of the trabecular
tissue and is independent of the nature of the fluid (Daish et al., 2017). In this study, the
permeability of each bone tissue element was characterized as isotropic and as a function
of bone porosity according to Equation 7.2 (Baroud et al., 2004):
k = B ψ1− ψ (7.2)
Where ψ is the bone porosity and B is a phenomenological parameter (0.394 · 10−8m2)
according to Baroud et al. (2004)). Bone porosity in an element is defined as the
proportion of space not occupied by bone tissue and therefore, was calculated for each
mesh element according to Equation 7.3:
ψ = 1−BV F (7.3)
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Where BV F is the Bone Volume Fraction of each element, previously calculated in
Chapter 4.
PMMA bone cement was modelled as a non-Newtonian fluid with shear thinning
behaviour, which implied viscosity decreased as shear rate increased. To replicate this
behaviour, PMMA viscosity was modelled in ANSYS Fluent with a User Defined
Function (UDF) relating viscosity of PMMA (η), shear rate (γ) and time elapsed after
mixing (t) as shown in Equation 7.4. This power law has been previously used in the
literature to describe pseudoplastic and rheopectic behaviour of bone cements (Baroud
and Yahia, 2004).
η =
(
a
t
ts
+ b
)(
γ
γs
)c( t
ts
)
+d
(7.4)
Where a, b, c and d are constants that depend on the material. For this work, parameters
of SimplexP bone cement were used (a = 590; b = −1048.8; c = −0.026; d = 0.29)
(Baroud and Yahia, 2004). Characteristic time (ts) was set to 1min and shear strain
rate (γs) to 1s-1. Also, for the simulation it was considered that the cement injection
started two minutes after mixing the PMMA. Material properties for both fluid phases
are summarised in Table 7.1.
Table 7.1: Material properties for CFD simulation
Properties Bone marrow PMMA
Density, kg/m3 1060 1480
Specific Heat, J/(kgK) 2670 1200
Thermal Conductivity, W/(mK) 0.28 0.25
Viscosity, kg/(ms) 0.0375 Eq. 7.4
Reference Temperature, K 310.15 293.15
The injection of bone cement into the bone was simulated using the CFD software ANSYS
Fluent. An unsteady laminar flow in the porous medium was modelled to analyse flow
characteristics and distribution of PMMA inside the femur. The simulation was conducted
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using the Volume of Fluid (VOF) method for two immiscible fluids: bone marrow and
PMMA bone cement. The VOF model is a surface-tracking technique designed for two or
more immiscible fluids where the position of the interface between the fluids is of interest
(Hirt and Nichols, 1981). Hence, at each time-step, the volume fraction (ϕbc) of each cell
was computed according to:
ϕbc = 1 Bone Cement Cells (7.5)
0 < ϕbc < 1 Interfacial Cells (7.6)
ϕbc = 0 Bone Marrow Cells (7.7)
The variable ϕbc defines the volume fraction of the bone cement phase within a finite
volume cell. Thus, ϕbc = 1 describes a finite volume cell containing only bone cement and
a value of ϕbc = 0 denotes a cell containing only bone marrow. According to its volume
fraction, the variables and properties in any given cell are either purely representative of
one of the phases, or representative of a mixture of the phases.
The computational domain used for this study included the proximal femur and a
retractable cannula. An inlet boundary condition, where PMMA entered the
computational domain was defined at the right end of the cannula. Three different
PMMA injection velocities were studied: 3.75mm/s, 7.5mm/s and 11.25mm/s. At the
other side of the cannula, both phases could exit the domain through the outlet, which
was set to atmospheric pressure. A dynamic mesh condition was created to simulate
retraction of the cannula (at a velocity of 7.5mm/s) as the bone cement entered the
domain. The rest of boundaries were defined as non-slip adiabatic walls. The
temperature of bone marrow was set to 37°C to replicate the human body temperature
and the PMMA temperature was set to ambient temperature (20°C). An initial pressure
of 2.3kPa was also assigned to the bone tissue in order to simulate the average
intraosseous pressure in the femur (Wingstrand et al., 1985). Furthermore, it was
assumed that the computational domain did not contain any bone cement in the initial
state.
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7.2.2 Thermal-Structural Analysis of Bone Cement
Polymerisation
After the injection simulation, the polymerisation of PMMA inside the bone was studied
using FEA. The numerical model that defined the PMMA curing process was an
adaptation of the one presented by Baliga et al. (1992); Lennon and Prendergast (2002);
Pe´rez et al. (2009). In this model, the polymerisation fraction (p) of cement was defined
as the ratio of the heat generated (S) at a time (t) divided by the total amount of heat
liberated per unit volume during the complete polymerisation process
(Qtot = 0.121J/mm3 according to Maffezzoli et al. (1997)):
p =
∫ t
0 Sdt
Qtot
'
∑n
i=1 Si∆ti
Qtot
(7.8)
The heat generation rate (S) was assumed to be a function of temperature and
polymerisation fraction (p):
S = R(T )pm(1− p)n (7.9)
Where R is an empirically obtained temperature-dependent function taken from the
literature (Baliga et al., 1992) and m and n are equal to 1. Therefore, the following
kinetic equation governed the bone cement polymerisation:
p˙ = 1
Qtot
R(T )(p− p2) (7.10)
The modulus of elasticity of PMMA at every instant depended on the modulus of elasticity
of the solidified PMMA (Esolidif = 2300MPa) and the degree of polymerisation (p). This
approach to simulate solidification, shown in Equation 7.11 was also adopted by Pe´rez
and Palacios (2010).
E = Esolidif · p (7.11)
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Material properties of bone tissue were derived from the CT scan following the
methodology presented in Section 3.2.1.
A new assumption in the proposed computational model was the consideration of both
thermal expansion (εthermal) and chemical shrinkage (εchemical) independently. Thermal
expansion was modelled using a constant coefficient (φ = 72.2 · 10−6K−1) and chemical
shrinkage was linearly related to the degree of polymerisation, with a maximum value of
2.56% (Gilbert, 2006).
εtotal = εthermal + εchemical (7.12)
εtotal = φ(T − Tref ) + (−2.56) · p (7.13)
This numerical model was applied to the 2D femur model and implemented in Matlab
R2019. ANSYS Mechanical APDL was used in batch mode to solve the transient thermal-
structural analysis at each time step. Results from the CFD simulation of Section 7.2.1
(Vinjection=7.5mm/s) were exported as two files: one that contained the distribution of
PMMA in the bone and other that contained the mesh of the model and the temperature
field. These two files were combined and converted to Ansys Parametric Design Language
(APDL) using a custom Matlab script.
A very small initial polymerisation fraction (p=10-6) was defined for the first time step
and after this, analyses were performed using a time increment of 1s for a total time
of 1000s. Thermal boundary conditions were defined at the external femur walls: heat
convection with ambient temperature of 20°C and a film coefficient of 1000W/(m2K).
Also, displacement of all external nodes of the bone (cortical tissue) were fixed. The
complete iterative procedure is depicted in Figure 7.2.
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Figure 7.2: Algorithm for the simulation of bone cement polymerisation.
7.3 Results
The bone cement distribution at different stages of the injection process
(Vinjection=7.5mm/s) and cannula retraction are shown in Figure 7.4. In the figure, a
PMMA volume fraction of 1 represents a cell containing only bone cement and a PMMA
volume fraction of 0 represents a cell containing only bone tissue. The injection was
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completed after approximately 8.5 seconds and due to the cannula retraction, the bone
cement was able to fill the drilled cavity homogeneously.
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Figure 7.3: PMMA distribution at different time steps of the injection process.
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Three different PMMA injection velocities (3.75mm/s, 7.5mm/s and 11.25mm/s) were
studied, resulting in changes to the amount of injected bone cement. The final PMMA
distribution for each aforementioned configuration is shown in Figure 7.4, covering an
area of 6.3cm2, 8.3cm2 and 10.7cm2 respectively. Assuming that bone cement spreads
similarly in the third dimension, this would be equivalent to injecting 4.1ml, 7.3ml and
12.2ml of PMMA.
Vinjection =  3.75 mm/s Vinjection =  7.5 mm/s Vinjection =  11.25 mm/s
Figure 7.4: Final PMMA distribution for different injection velocities.
The average intraosseous pressure was also monitored during PMMA injection and is
depicted in Figure 7.5. In all models, an initial intraosseous pressure of 2.3kPa was
defined, which can be observed at t=0s. After this, pressure increased at different rates
depending on the bone cement injection velocity. Higher velocities resulted in larger
amounts of PMMA being injected and subsequently higher pressure. Maximum pressure
increase recorded for each injection velocity was 6.45kPa (at 3.75mm/s), 10.52kPa (at
7.5mm/s), and 18.65kPa (at 11.25mm/s).
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Figure 7.5: Pressure vs Time for all studied cases.
After the CFD analysis, a transient thermal-structural FE simulation was conducted to
replicate the bone cement curing process. Figure 7.6 shows the evolution of the
polymerisation fraction (p) over 1000s of the simulation in all the PMMA domain
(shown in grey). The average degree of cure was also plotted (shown in red), which
reaches a value of 1 approximately 400s after the simulation starts. It can be seen that
the chemical process of polymerisation was different for each element yet completed
within the specified time in all cases.
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Figure 7.6: Evolution of the degree of cure with time.
The initial temperature distribution in the curing process was taken from the CFD
simulation results (Figure 7.7). Hence, as PMMA was injected at ambient temperature
(20°C), its initial temperature was lower than the femur temperature (37°C). After
approximately 300 seconds, convection allows PMMA temperature to reach body
temperature. Subsequently, the exothermic reaction associated with bone cement curing
generates an increase in the PMMA temperature.
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Figure 7.7: Initial temperature distribution from CFD calculations.
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In Figure 7.8 it can be observed that peak temperatures reached at the PMMA-bone
interface (locations A, B) were lower than the ones generated inside the PMMA (location
D). Similarly, bone tissue sufficiently distant from the bone cement (location C) was
not affected by the exothermic reaction of the curing process. The peak temperature
reached in the bone cement mantle was 96°C, while maximum temperature recorded at
the interface was 89°C.
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Figure 7.8: Evolution of the temperature during the bone cement curing process at different
locations.
120
CHAPTER 7
In order to evaluate the possibility of thermal necrosis, the proportion of bone tissue
exposed to temperatures exceeding 40°C 50°C and 60°C was plotted against time (Figure
7.9). Over 20% of the bone was exposed to a temperature higher than 40°C during a
large part of the study (after t=360s). Temperatures above 60°C occurred in a smaller
fraction of the bone tissue (2%) and in smaller periods of time (from t=360s to t=520s).
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Figure 7.9: Percentage of tissue exposed to a temperature exceeding specific levels.
Besides the changes in temperature, the PMMA polymerisation process also has an effect
on bone and PMMA mechanics. Stresses can arise in the bone tissue due to the thermal
expansion and chemical shrinkage of bone cement. In the FE analysis all the femur
external nodes were fixed and therefore, the total area of the domain was forced to remain
constant. Several investigations have reported that shear stress can be studied to evaluate
debonding between PMMA and bone tissue (Hung and Chang, 2010). In this study, the
maximum developed shear stresses were within the range of 0.5 to 1.3MPa and found near
the greater trochanter and the superior part of the PMMA distribution (Figure 7.10).
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Figure 7.10: Shear stresses generated due to the PMMA curing process.
The Von Mises stress distribution generated due to the curing process is shown in Figure
7.11, reaching a maximum value of 3.6MPa near the cortical region and in the superior
region of the PMMA distribution.
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Figure 7.11: Von Mises stresses generated due to the PMMA curing process.
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7.4 Discussion
A computational framework for modelling bone cement injection and polymerisation in
the femoral augmentation procedure was presented in this chapter and applied to a 2D
femur model. In the study, a CFD analysis was performed to investigate heat transfer
and fluid flow characteristics during the PMMA injection process. Detailed material
properties were applied to PMMA bone cement in order to replicate its rheological
behaviour and bone tissue was modelled as a porous medium. After this,
thermal-structural FE simulations were conducted to simulate bone cement curing. The
model used to represent polymerisation included curing kinetics, heat generation,
evolving mechanical properties, chemical shrinkage and thermal expansion.
Femoral augmentation was performed on a single specimen using three different PMMA
injection velocities and hence, three related PMMA bone cement volumes. The
generated femur was a two-dimensional macroscale FE model, assuming trabecular bone
as a continuum solid. Although micro-FE models may have provided more accurate flow
and bone cement distribution results, they also require very high computational
resources. For this reason, most micro-FE models studied in the literature (Zeiser et al.,
2008; Landgraf et al., 2015; Ramos-Infante et al., 2018) focus on an osteoporotic
trabecular structure and do not consider the whole bone. Hence, such models do not
allow for the visualization of the PMMA distribution after augmentation.
A power law was implemented based on the work of Baroud and Yahia (2004) capable of
modelling both pseudoplastic (shear-rate dependent viscosity) and rheopectic (time
dependent viscosity) behaviour of PMMA bone cement. CT scan data was used to
create a femur geometry and derive the bone permeability of each mesh element.
Permeability was the main factor affecting distribution of PMMA in the bone tissue and
was modelled as an isotropic parameter, dependant on the bone volume fraction of each
element. This assumption is acceptable for the 2D representation of vertebral bodies but
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given the complex trabecular structure of the proximal femur (Syahrom et al., 2015) the
validity of this simplification remains unclear. Homogeneous distributions of bone
cement filling the pre-drilled channel were achieved at the end of the injection process.
This was achieved by the inclusion of cannula retraction during the injection. Since the
majority of investigations regarding bone cement injection in macroscale bone models
are related to vertebroplasty, which does not involve cannula retraction, no other
frameworks have considered cannula displacement. However, experimental studies of
femoral augmentation using a pre-drilled channel (Beckmann et al., 2011; Steenhoven
et al., 2011; Springorum et al., 2014) have found bone cement distributions similar to
the ones of this chapter.
PMMA injection rate is an important parameter in any bone augmentation surgery, since
it influences volume of injected PMMA, injection pressure and possibility of leakage.
In this study, increasing PMMA injection velocity also increased the amount of bone
cement injected in the cavity. Assuming bone cement spreads in a similar manner in
the third dimension, volumes ranging from 4.1 to 12.2ml were introduced in the femur.
Furthermore, depending on the PMMA injection velocity the peak pressure recorded in
the simulation ranged from 6.45 to 18.65kPa. Higher pressures were found by Wang et al.
(2013) who injected 2-6ml of PMMA in a vertebroplasty and reported an intraosseous peak
pressure of 22.5±6.2kPa. However, Reidy et al. (2003) and Baroud et al. (2005) reported
peak intravertebral pressures during vertebroplasty of 6.83±10.4kPa and 3.54±2.91kPa
respectively. Peak intraosseous pressure during augmentation depends on a variety of
factors such as rheology of the injected bone cement, velocity and type of injection, and
material properties of the bone. This can explain variation in results obtained for in vitro
vertebral augmentation cases and shows the importance of computational models. In
the present study no gap was modelled between the cannula and the bone and therefore,
leakage could not be studied.
One of the resultant CFD models, representing a PMMA injected volume of 7.3ml was
converted into a FE model to investigate the bone cement curing process. 508 seconds
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after injection the bone cement was fully cured, although the polymerisation rate of each
element depended on its initial temperature. In the present study, high initial
temperatures increased the rate of curing and heat evolution, as reported by Landgraf
et al. (2015). Existing models considering PMMA polymerisation as a
temperature-independent process (Jefferiss et al., 1975; Swenson et al., 1981) cannot
account for this effect. On the other hand, more complex models also account for the
leftover monomer concentration during solidification (Mazzullot et al., 1991; Stanczyk
and Rietbergen, 2004) or three different phases of the polymerisation process (Hansen,
2003). These models may further enhance the findings presented this chapter, although
the model used in this study was sufficient to predict the curing behaviour of the bone
cement and results are in agreement with previous numerical and experimental studies
(Landgraf et al., 2015; Arens et al., 2011).
The exothermic reaction generated during the PMMA polymerisation process can cause
thermal necrosis in any bone augmentation procedure. Therefore, in order to evaluate
risk of thermal necrosis in the femoral augmentation proposed in this chapter, results
of the thermal-structural analysis were analysed. Thermal necrosis has been reported in
bone tissue exposed to temperatures higher than 56°C for more than 10 seconds (Pearce
et al., 2005). According to the present results, bone tissue regions adjacent to the injected
PMMA are subject to temperatures of up to 89°C for over 50 seconds. It seems likely
that those regions of the bone will suffer from thermal necrosis and not survive. However,
since bone located at the interface is embedded within PMMA, it cannot remodel, and
it is likely to remain intact and capable of transmitting loads (Stanczyk and Rietbergen,
2004). When checking temperatures in regions further away from the interface (5mm from
the interface) figures are much lower, reaching a maximum of 55°C for 30 seconds. Hence,
it is unlikely that thermal necrosis would propagate further away from the interface and
affect bone tissue not embedded in bone cement.
Similar peak temperatures at the bone-cement interface were found by Stanczyk and
Rietbergen (2004), who simulated the curing process in a 3D model of a bone trabecular
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structure and reported a peak temperature of approximately 70°C, 19°C lower than the
one found in this chapter. However, theirs is a microscale model and the bone cement
volume studied is significantly smaller than the one of the present study. A computational
study at macroscale level replicating a total hip arthroplasty was performed by Pe´rez et al.
(2009), who reported peak temperatures between 46.3 and 54.9°C in the femoral stem.
These lower temperatures are expected since the bone cement was spread in a 5mm layer
around a steel cylinder and the temperature was measured in the steel stem. In addition
to numerical simulations, experiments have also been performed in the past with the
objective of measuring the bone cement temperature during the curing process (Arens
et al., 2011; Jiang et al., 2015; Tai et al., 2016). In those experiments, bone cement
was shaped into cylindrical samples similar to the bone cement distribution obtained in
this chapter due to the cannula retraction. Therefore, temperature measurements from
those experimental studies were compared against the temperature evolution at the bone-
cement interface obtained in the present study (Figure 7.12). Results in terms of peak
temperature and settling time are varied and depend on the size and geometry of the
mold where bone cement was injected (Vallo, 2002), temperature measurement location,
bone cement brand and ambient temperature. However, despite the differences all graphs
show the same trend and the temperatures reached in the present study are within a
reasonable range. Without any further experiments that replicate the same conditions
applied in this chapter, it is not possible to fully validate our model, but results show the
same trends found in experimental studies of cylindrical PMMA samples.
Apart from high temperatures generated in the curing process, changes in the bone cement
volume can occur due to thermal expansion, chemical shrinkage and the applied boundary
conditions. Bone cement is known to shrink up to 2.56% during polymerisation (Gilbert,
2006), and due to the high temperatures in the curing process, thermal expansion is also
likely to occur. Stresses generated during the curing process by these effects may cause
debonding and affect augmentation performance. Wide variability has been reported in
previous studies evaluating the debonding of bone and PMMA. Hung and Chang (2010)
found that shear stresses higher than 4.72-7.98MPa can lead to the separation of the
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Figure 7.12: Temperatures developed in the PMMA curing process obtained in previous
experimental studies and in the present chapter.
two materials. Similar values were presented by Dohmae et al. (1988), while Bean et al.
(1987) reported stresses in the range of 6-15MPa. The highest shear stress found at the
bone-cement interface in this study was 1.3MPa. However, obtained results can only be
used as an indication of the locations that are likely to suffer debonding. More detailed
modelling of the interface could help obtain more accurate results in this aspect.
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Conclusion and Future Work
8.1 Summary
The present study numerically investigated femoral augmentation in six femur models
with different levels of osteoporosis and osteopenia. Osteoporosis was virtually
introduced as a uniform reduction of the elastic modulus, which is a valid assumption
for senile osteoporosis (Type 2), common in male population. The osteoporotic and
osteopenic models were not validated experimentally, but a good agreement was found
when comparing the yield load of the created models with the yield or fracture load
found in previous experimental and computational studies (Sutter et al., 2010a,b;
Falcinelli et al., 2014).
After developing the models, Chapter 3 focused on identifying the ideal bone cement
volume and distribution needed to restore the load capacity of the examined femora. To
do so, an Evolutionary Structural Optimisation (ESO) algorithm was applied to the FE
models while replicating a lateral fall on the greater trochanter. The algorithm found
the ideal locations where bone cement should be injected to increase the femur yield
load by at least 100%. This ideal bone cement distribution comprised reinforcing the
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greater trochanter, superior aspect of the femoral neck and, in some cases, a ring around
the femoral neck. However, since the ESO was not constrained to create shapes that
are injectable in practice, these distributions were formed of clusters of bone cement,
not necessarily connected to each other. For this reason, in all femora the required
volume of bone cement to at least duplicate the original femur yield load was small
compared to previously published data from experiments or simulations. Additionally, a
linear correlation between the femur T-Score and optimum volume of bone cement was
demonstrated and as expected, larger volumes of bone cement were required to obtain a
predefined level of augmentation in weaker femora (2.98ml in femur with T-Score -1.0 vs
18ml in femur with T-Score -3.5).
Some of the limitations of Chapter 3 were addressed in Chapter 4, such as the fact that
in practice, bone cement is embedded in trabecular tissue and hence, the material
properties of augmented tissue should also depend on the original properties of the
bone. Besides, bone cement porosity, developed due to shrinkage and during the PMMA
mixing phase, may also have an effect on the augmentation performance. Therefore, five
different approaches were employed and compared to calculate the elastic modulus of
the augmented tissue: pure PMMA, pure PMMA with porosity, bone-PMMA
composite; bone-PMMA composite with porosity and bone-PMMA composite neglecting
bone tissue. From these approaches, the first two are widely used in the literature and
were proven to be significantly different to each other in the context of femoroplasty
(p=0.048). The fourth scheme, which combined Voigt-Reuss-Hill average and bone
cement porosity was considered to be the most physiologically realistic in femoral
augmentation and provided results that were not statistically different to the rest of
approaches. Hence, for the rest of the thesis this was the method used to simulate
augmented tissue. Moreover, results from the sensitivity analysis conducted in Chapter
4 suggest that the two variables that have the highest influence in the augmentation
requirements are the femoral rotation in the frontal plane (internal rotation) and the
level of bone cement porosity. Increasing the femur internal rotation during a fall or
using bone cement with high porosity has a negative effect in the augmentation result.
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The ideal bone cement pattern found in Chapter 4 was used as a reference to propose
several feasible, generalised augmentation strategies in Chapter 5. These augmentation
strategies were chosen because they are achievable in practice and in most cases, there is
experimental evidence that it is possible to create such distributions inside the femur.
They comprised the injection of up to three spheres of bone cement or the injection of
bone cement in up to two pre-drilled channels. For all proposed augmentation strategies,
a Taguchi analysis was conducted and it was found that bone cement location was more
important in the augmentation result than bone cement volume. Therefore, based on
these results the location of bone cement in the proposed generalised augmentation
approaches was optimised using a patternsearch algorithm. Once optimised, all
augmentation strategies performed similarly (average increase of 71% with spheres of
bone cement and average increase of 79% with pre-drilled paths), although injection of
three spheres of bone cement required larger amounts of bone cement (8.6ml vs 7.3ml).
Given the similarity of results, the choice between approaches should depend on
replicability and potential clinical risks. Despite injecting three spheres of bone cement
may reduce the risk of thermal necrosis (they can be injected separately, waiting until
polymerisation of each sphere is completed), it is harder to control how the bone cement
would spread, it may damage the cortical bone excessively if it needs to be drilled more
than once and it may require detailed pre-operative planning. Augmentation in
cylindrical pre-drilled channels may be easier to replicate in practice, although the risk
of thermal necrosis may be higher and would need to be evaluated before the procedure.
Since most experimental work in femoral augmentation involves injecting bone cement
in one or two pre-drilled channels, the fracture analysis of augmented femora (in
Chapter 6) was conducted using the optimised results of the aforementioned approaches.
A nonlocal damage model was applied to investigate bone fracture patterns, fracture
load and energy to fracture in the augmented and non-augmented femur models with
different degrees of osteoporosis and osteopenia. A significant increase in yield load,
fracture load and energy to fracture was found after augmentation with approximately
7ml of bone cement: 74% increase of femur yield load, 62% increase of fracture load and
130
CHAPTER 8
117% increase of energy to fracture in a femur with T-Score -2.5. Through comparison
with existing literature it was found that the optimised augmentation strategies
proposed in this study performed better than non-optimised existing approaches tested
both numerically and experimentally. It was also shown that when using a predefined
volume of bone cement, weaker bones obtained greater benefits from augmentation
(relative fracture load increase of 81% in femur with T-Score -3.5 vs 45% in femur with
T-Score -1.0). In the fracture analyses, the fracture paths generated in augmented and
non-augmented femora were also studied and compared. Although fracture patterns did
not change significantly after augmentation, small cracks were generated closer to the
femoral head in augmented models, suggesting augmented femora may be at higher risk
of comminuted fractures. However, despite results are in agreement with trends found in
previous experiments, the findings of this study are only valid for a single femur and a
larger sample size would be required to draw general conclusions.
Finally, Chapter 7 was dedicated to evaluate some of the risks involved in femoral
augmentation such as thermal necrosis, excessive intraosseous pressure, and bone and
cement debonding. Therefore, a methodology was proposed to simulate the bone cement
injection and curing process and was applied to a 2D femoral augmentation procedure.
Results showed that after injecting approximately 7ml of bone cement, the risk of
thermal necrosis was limited to the regions in the bone-PMMA interface and debonding
was not likely to happen. It was also shown that the regions more likely to suffer from
debonding or stress concentration were near the superior aspect of the femoral neck.
This might be a reason for concern since this is the initial region of failure in the event
of a lateral fall onto the greater trochanter. Additionally, after comparison with existing
literature it was found that results in terms of peak temperature and possibility of
debonding depend on a variety of factors such as the brand and type of bone cement
and its distribution inside the bone. Therefore, experiments that replicate the femoral
augmentation procedure as depicted in Chapter 7 would be necessary to validate the
model.
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Despite the limitations of the present study and lack of direct experimental validation,
the methodology developed in this thesis can be applied to plan and optimise a femoral
augmentation intervention in any femur. After applying them to a single femur with
different degrees of osteoporosis, we conclude that femoral augmentation with a limited
volume of bone cement can result in significantly increased yield and fracture load without
significant risks. So far, the requirements and risks of the procedure are subject-specific,
although applying this study to a larger sample size could help in the development of
augmentation strategies that are beneficial to a large part of the population at risk of
osteoporotic fractures.
8.2 Limitations and Future Work
In the present study there are certain simplifications and limitations that could be
addressed in future work. One of them concerns the fact that osteoporosis was virtually
introduced in the developed models in a way that would only represent senile
osteoporosis (in senile osteoporosis there is a uniform reduction of material properties in
the cortical and trabecular tissue). However, hip fractures are also likely to occur in
people with postmenopausal osteoporosis. In this case, the degradation of material
properties is not homogeneous in the cortical and trabecular tissue and therefore, the
requirements and outcome of femoral augmentation might be different. Hence, despite
the yield and fracture loads of the developed models were compared and showed good
agreement with experimental data from previous studies, only one femur geometry was
studied with senile osteoporosis. A larger sample size, including male and female
osteoporotic models, with different geometry and type of osteoporosis (I and II) could
help derive more meaningful results.
In addition to a larger sample size, suitable experiments fracturing augmented and non-
augmented femora could be performed in order to validate the results obtained in this
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numerical study. Cadaveric or synthetic femora could be augmented by injecting cement
in pre-drilled channels or in spheres and test conditions that replicate a lateral fall could
be applied. With this, it would be possible to find the augmented yield and fracture load
and potential changes in fracture patterns due to augmentation. Other test conditions
that have not been investigated in this research could also be applied. Although most
osteoporotic hip fractures occur due to a fall, patients with severe osteoporosis might
develop a fracture when walking or climbing stairs. As expected, the sensitivity analysis
conducted in Section 4.2.2 found that fall direction affects augmentation requirements.
However, a more detailed study of different boundary conditions, from standing to fall in
different directions could improve the efficacy of the augmentation strategies. Similarly,
combining results from these simulations with epidemiological data of the most common
types of fall could enhance the augmentation requirements.
All the simulations performed in this thesis were static due to the complexity and
computational costs of dynamic simulations. However, they do not accurately represent
a dynamic event like a fall on the side. Hence, changing the existing simulations to a
dynamic impact analysis, accounting for the person’s height and weight and the
damping effects of soft tissue would increase the accuracy in representing a fall.
The present study also included the development of a framework to simulate bone
cement injection and solidification, but it was only applied to a 2D femur model. This
could be enhanced by small modifications that allow application to a 3D model,
considering anisotropic permeability of trabecular tissue. Additionally, in order to
validate the model, bone cement could be injected into cadaveric or synthetic femora
while monitoring the temperature with thermocouples in different locations. The final
bone cement distribution in simulations and experiments could also be compared after
performing X-ray in the augmented bone. Given the different available commercial bone
cements and the sensitivity of the curing process to the type of bone cement, this
methodology could be used to study the effect of the fluid rheology in the risks involved
in femoral augmentation. Besides, cooling the femur prior to augmentation may be
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studied as an alternative to minimise the risk of thermal necrosis and changes in the
bone cement injection and solidification process could be monitored.
Finally, all the methodologies developed in this study could be combined to build a
tool that could help surgeons plan the augmentation procedure. This tool should use
the femur CT scan as input and provide realistic and easy to implement augmentation
strategies for the specific femur (such as filling with bone cement one or two pre-drilled
cavities). Variables like the type of bone cement and ambient temperature in the operation
room could be changed. The risks and benefits involved with each bone cement and
augmentation strategy would be provided and may help the surgeon in the decision-
making process. In order to replicate in practice the simulated augmentation, parameters
such as the inclination of the drill, diameter of the drill bits and injection velocity would
be provided.
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